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GENERAL INTRODUCTION 
"Modern swine production makes great demands on the 
potential of sows to reproduce efficiently" and the sow's 
ovaries are a primary regulator of all reproductive processes 
(94). The corpus luteum (CL) is an endocrine organ present on 
the sow ovary throughout the majority of the estrous cycle. 
The CL is potentially the most important ovarian structure in 
the regulation of reproductive processes such as the length of 
the estrous cycle and the success of pregnancy of the sow. In 
support of this hypothesis, CL must be present on the sow 
ovary and producing progesterone in order for pregnancy to be 
maintained (54). Progesterone supplied by the CL prepares the 
uterus for pregnancy by inducing epithelial cells to change 
from a highly proliferative state to a secretory state. 
Secretory products of epithelial cells provide nourishment and 
support to the conceptus. Moreover, progesterone produced by 
the CL blocks the organized contraction of the myometrium 
which would be detrimental to the embryo. In addition, the 
proper regulation of the CL is also important at the time of 
parturition, as regression of the CL and cessation of 
progesterone production are essential for normal uterine 
contractility and expulsion of the litter. Failure or 
incomplete luteal regression may cause prolonged gestation and 
early post parturient lactation failures in the sow (94). 
2 
These conditions can be costly to the pig producer as they 
result in a reduction in the number of litters/sow/year and an 
increase in the number of idle days (absence of pregnancy or 
lactation) per sow. 
The lifetime of the CL is controlled by product(s) of 
uterine origin which destroy the CL (luteolysin) and the 
product(s) of embryonic origin which protect the CL 
(luteotrophin). The mechanism of action of these products, 
however, is not completely understood. Modern pig farming 
management practices are most efficient if minimal effort is 
placed into the reproductive management of sows. Therefore, a 
more complete understanding of luteal function would allow the 
development of novel and efficient methods to enhance the 
reproductive efficiency of the sow which would benefit the pig 
farmer. 
Objectives of Dissertation Research 
Several lines of evidence suggest that the immune system 
plays an important role in luteal function. The objective of 
this dissertation, therefore, was to study the relationship 
between macrophages (a cell type important in most aspects of 
an immune response) and luteal life span with emphasis on the 
process of iuteolysis. The specific objectives were 1) to 
establish the temporal association between macrophage 
infiltration into the CL and functional Iuteolysis (as 
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measured by a decline in progesterone); and 2) to localize a 
primary cytokine of macrophages, tumor necrosis factor (TNF) 
in the pig CL during the estrous cycle and throughout 
pregnancy. 
Explanation of Dissertation Format 
The research presented in this dissertation examines the 
interaction between two physiologic processes, reproduction 
and immunology. Therefore, the Literature Review includes 
discussion on both CL and macrophage function and attempts to 
examine potential interactions between luteal regression and 
macrophage infiltration. The Literature Review precedes two 
manuscripts. The first manuscript has been accepted by 
Biology of Reproduction, the second manuscript will be 
submitted to The Journal of Reproduction and Fertility. Each 
manuscript is in the format of the journal intended for 
publication. A General Summary and Discussion follows the 
last manuscript. References cited in the Literature Review 
and the General Summary and Discussion sections can be found 
in the Additional Literature Cited section. 
Karen E. Hehnke was the principal investigator for all 
studies presented in this dissertation. 
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LITERATURE REVIEW 
Physiology of the Corpus Luteum 
The CL is formed from the hemorrhagic tissues of the 
ruptured ovulatory follicle through the proliferation and 
differentiation of thecal and granulosa cells (25). Moreover, 
migration and proliferation (angiogenesis) of endothelial 
cells from existing blood vessels through the fragmented 
vascular basement membrane of the ovulatory follicle is an 
important part of CL formation (25). 
The luteal cells present in the CL of the pig consist of 
two morphologically distinct populations, large luteal cells 
(LLC) and small luteal cells (SLC) (39). While other theories 
exist, it is generally accepted that the follicular granulosa 
cells "mature" into LLC while the theca cells from the 
follicle "mature" into SLC (28,69). The volume of the mature 
CL occupied by LLC is 25-35%, whereas SLC comprise 12-18% of 
the CL volume, and approximately 50% of the cell population 
(or 11% of the volume) of the CL are endothelial cells. 
Moreover, the majority of the SLC and LLC are adjacent to one 
or more capillaries (62). The remaining volume of the mature 
CL is occupied by connective tissue (22-29%) and fibroblasts 
(7-11%) (54). 
The CL is an ephemeral endocrine organ in that it will 
regress and become non-functional in cyclic (non-pregnant) 
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animals. The primary function of the CL is the production and 
secretion of progesterone, a hormone essential for the 
maintenance of pregnancy (54). 
Steroidogenesis 
The process of progesterone synthesis begins when 
cholesterol or lipoprotein bound to low-density lipoprotein 
and high-density lipoprotein receptors on luteal cells is 
internalized via endocytosis. Following endocytosis, 
endosomes combine with lysosomes and liberate cholesterol 
which is esterified. Esterified cholesterol is then 
transported to the mitochondria of the luteal cell where it is 
converted to pregnenolone by the multienzyme complex commonly 
termed cytochrome P450 side chain cleavage (SCC). 
Pregnenolone is subsequently converted to progesterone by a 
microsomal enzyme or enzyme complex A^-36-hydroxysteroid 
dehydrogenase; AS-4 isomerase (3BHSD). The rate limiting step 
of progesterone synthesis is believed to be the conversion of 
cholesterol or lipoprotein into pregnenolone by SCC (26). 
This is consistent with the observation that virtually all SCC 
are saturated with cholesterol throughout the estrous cycle 
yet there is an obvious decrease in SCC association with 
cholesterol during regression of the CL (luteolysis; days IS­
IS; day 0 = first day of estrus). This decrease is 
significant by day 17 of the 21 day pig estrous cycle (79). 
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Small luteal cells have the capability to produce 
progesterone, and are dependent on luteinizing hormone (LH) 
for this production. In contrast, LLC are the primary source 
of progesterone and do not depend on LH for progesterone 
synthesis. Ultrastructurally, LLC possess all characteristic 
elements of protein and steroid secreting cells including 
numerous mitochondria and abundant smooth endoplasmic 
reticulum (41). 
Regression of the pig CL occurs between days 15-18 of the 
estrous cycle if the pig is not pregnant. Two stages of 
luteal regression have been described, functional regression 
and structural regression. Functional regression is 
characterized by a decrease in progesterone secretion by 
luteal cells while structural regression occurs, in part, by 
phagocytosis of degenerating cells by macrophages (54). 
Prostaglandin Fg*: the Uterine Luteolytic Substance 
in the Pig 
The first evidence of uterine involvement in the 
luteolytic process was presented in 1923, (as reviewed by 
Nisewender and Nett; 54), when Loeb reported that removal of 
the uterus lengthened the life span of CL in guinea pigs. 
Since then, uterine involvement in luteolysis has been 
reported in many species including the pig. By 1969, Pharris 
and Wyngarden (60) provided evidence that prostaglandin-Fj^ 
(PCF) was luteolytic in the rat. Presently, several lines of 
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evidence exist which suggest PGF is the endogenous agent 
responsible for luteolysis in domestic livestock (as reviewed 
by Knickerbocker et al.; 39). In pigs, elevated 
concentrations of PGF in uterine venous drainage, uterine 
tissue and uterine flushings coincide closely with the period 
of expected luteolysis (39) . More importantly, the frequency 
and amplitude of episodic changes in PGF plasma concentration 
in the uterine ovarian vein are higher in the pig (46), sheep, 
and cow (78) during luteolysis than during pregnancy. In 
domestic livestock, inhibition of uterine prostaglandin 
production by indomethacin treatment blocks spontaneous luteal 
regression. Furthermore, luteolysis is prevented following 
passive immunization with PGF antibody. Finally, data from 
cattle and sheep show a local exchange of PGF from the uterine 
venous drainage into the ipsilateral ovarian arterial supply 
(39) . 
Prostaglandin F2a was shown to be luteolytic in 
bilaterally hysterectomized gilts on day 14 but not on day 11 
(78). Further studies showed that infusion of PGF into the 
uterine vein over a 10 h period on day 12, 14 or 15 of the 
estrous cycle induced luteolysis. Yet luteolysis did not 
occur with a similar infusion of PGF on day 6, 8 or 10 of the 
estrous cycle. These data suggest that PGF is e fective in 
killing the CL only after a specific point of the estrous 
cycle. Coincident with this specific time of PGF 
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susceptibility, is the fact that embryos must be present in 
both uterine horns between day 11 and 12 to maintain pregnancy 
in the pig (78). Furthermore, removal of all embryos on day 
13 but not day 11 results in extended CL lifespan (78). Thus 
the antiluteolytic effect of the pig embryo is evident by day 
13 (78), a time of maximal estrogen secretion by the 
preimplantation embryo. Therefore, it is generally accepted 
that uterine PGF is the luteolytic substance for pig CL, while 
estrogen produced by embryos acts as a luteotrophin and 
inhibits the secretion of PGF from the uterus into the uterine 
vein. 
Effects of PGF on the CL 
The exact mechanism(s) utilized by PGF to induce 
luteolysis is unclear. The luteolytic effects of PGF are 
thought to occur, in part, through its direct interaction with 
the luteal cells. By day 14, PGF receptors are present on pig 
luteal cells (24) and, at this time, the CL becomes 
susceptible to the luteolytic effects of PGF. Additionally, 
PGF is thought to act indirectly via a rapid reduction in 
blood flow to the CL (52). 
The most extensive morphological examination of events 
which occur in the CL during regression have been studies of 
the guinea pig CL (3). Morphological changes during 
luteolysis of sheep and pig CL are virtually identical (11,52) 
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to changes noted in the guinea pig CL. Therefore the 
following sections summarize the available information on 
morphological changes in the CL during luteolysis. In an 
attempt to provide a complete picture of events that occur 
during luteolysis, observations made in the guinea pig, sheep 
and pig CL during luteolysis will be discussed. 
Prostaglandin effects on endothelial cells. By 
day 16 of the guinea pig estrous cycle (a time when luteal 
regression in the guinea pig has occurred), a degeneration of 
capillaries had occurred, yet many capillaries appeared normal 
(3). Changes observed at luteolysis affected individual 
cells, apparently randomly, while neighboring cells frequently 
appeared normal and viable. The number of capillary 
endothelial cells and pericytes become dramatically reduced 
during luteal regression. Coincident with morphological 
changes of the CL was a decline in blood flow to the ovary and 
a reduction of progesterone secretion by the CL. Other 
endothelial cell changes included a protrusion of this cell 
type into the capillary lumen, an increase in the size and 
number of membrane junctions between endothelial cells, an 
overlapping of endothelial cells, nuclear and cytoplasmic 
condensation of endothelial cells, and lobulation in 
endothelial cells either within capillary walls or lying 
apparently within capillary lumina. Cellular fragmentation of 
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endothelial cells also occurred, and an increase of 
degenerating cell fragments (apoptotic bodies) within 
cytoplasmic vesicles of normal endothelial cells was noted. 
As luteolysis continued, there was a complete degeneration of 
capillaries. These morphological changes are described in 
detail by Axmi and O'Shea (3). 
Morphological characteristics of endothelial cells during 
the regression of the CL are essentially identical with 
characteristics of apoptosis. Results from a study by Sawyer 
et ai., (69) established that luteal endothelial cells undergo 
apoptotic cell death and are sloughed into the lumina of the 
small blood vessels during luteolysis. Compared to luteal 
fibroblast and steroidogenic cells, nuclear changes indicative 
of apoptosis were first evident in endothelial cells (69). 
From these data it is apparent that luteal endothelial cells 
are a primary target for the luteolytic effects of PGF. 
Therefore, if the blood supply is lost, the CL will die. 
Prostaglandin effects on fibroblast and steroidogenic 
cell populations of the CL. The vasoconstrictive effects 
and/or cell mediated activities of PGF possibly contributes to 
the functional and structural alterations of cell populations 
other than endothelial cells during luteolysis (39,52). For 
instance, fibroblasts in the regressing CL undergo nuclear and 
cytoplasmic condensation. Moreover, the early effects of PGF 
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(within 24 h) on luteal cells include chromatin condensation 
and vesiculation of the cytoplasm with an accumulation of 
lipid droplets in the cytoplasm (69) . These effects on luteal 
cells do not occur synchronously. For example, during 
luteolysis the nucleus of some parenchymal cells show 
margination while other cells appear normal. A decline in 
protein-containing secretory granules in LLC also occurs early 
in luteolysis consistent with a reduction in secretory 
capacity of LLC. Additionally, densely staining secretory 
granules observed in LLC when progesterone secretion is 
maximal, decrease in number throughout the period of luteal 
regression (54). 
As luteolysis progresses, lysosomes and autophagosomes in 
luteal cells increase in number. Also, an exocytosis of 
secretory granules in LLC occurs (19). Moreover, the 
intracellular organelles of steroidogenic cells become 
increasingly disorganized and the number of steroidogenic 
cells declines. However, the activity of numerous enzymes 
responsible for luteal steroidogenesis, energy metabolism, 
post translational protein modifications and autolysis are 
generally not altered until functional luteolysis has begun 
and plasma concentrations of progesterone have fallen (39). 
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Prostaglandin effects on second messengers. To 
date, very few studies have examined the effects of PGF on 
luteal cell second messengers in vivo. However, in vitro 
studies suggest several effects of PGF on second messengers 
within luteal cells. 
Prostaglandin Fg^ increases phosphoinositide breakdown in 
ovarian cells of rats, cows, pigs, and sheep (28,74,92). One 
effect of phosphoinositide breakdown is membrane disruption 
and an influx of calcium into cells. Wiltbank et ai., (92) 
showed that treatment with PGF causes a dramatic increase in 
free intracellular concentrations of calcium within large but 
not small luteal cells. This observation suggests that LLC 
and SLC have functional differences, with PGF responsiveness 
being localized to LLC which have high affinity PGF receptors. 
Sustained elevation in free intracellular calcium is cytotoxic 
to many cell types and is likely to be cytotoxic to LLC as 
well. For example, results of increased intracellular calcium 
levels in LLC could include activation of a calcium dependent 
endonuclease, calcium activated DNA fragmentation, calcium 
induced swelling of cells as a result of increased 
permeability of membranes resulting from calcium dependent 
phospholipid hydrolysis, and calcium induced free radical 
formation. Many of these effects of increased calcium levels 
in cells are consistent with changes noted in luteal cells 
during luteolysis (3). 
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Prostaglandin activates protein kinase-C (PKC) which 
results in the acute inhibition of progesterone production by 
luteal cells within the first 8 hours of PGF treatment (92). 
Activation of PKC in SLC results initially in increased 
progesterone production and increased production of 
arachidonic acid (AA) and its metabolites (PGF, prostaglandin 
E-2 and prostaglandin 1-2). Chronic activation of PKC in SLC 
desensitizes LH-induced progesterone production. Furthermore, 
high levels of arachidonic acid (AA) and/or its metabolites 
induced by PKC result in high concentrations of intracellular 
calcium in LLC (92). 
Another effect of PGF on luteal cells is a decrease in 
Na+-K+-ATPase activity within an hour after treatment (as 
reviewed by Stormshak et al.; 74). Potential effects of the 
decrease of this ion pump include a reduction of available 
energy (ATP) and the disruption of the ionic balance of the 
cell which would result in swelling and eventual lysis of the 
cell. 
Examples of reactive oxygen species include H2O2, 
superoxide anion and hydroxyl radicals. Lipids, proteins and 
DNA are all targets for reactive oxygen species. Reactive 
oxygen species initiate a series of damaging biochemical 
events which inclide membrane damage, disruption of ion 
channels, and destruction of DNA (37). Furthermore, reactive 
oxygen species stimulate the formation of chemotactic factors. 
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leukocytic invasion and leukocyte activation (37). 
Prostaglandin stimulates the production of reactive oxygen 
species by rat luteal cells in vitro and specifically causes 
an increase in H2O2 concentration in regressing rat CL in vivo 
(58). The damaging biochemical events attributed to reactive 
oxygen species, such as membrane disruption and damage of DNA, 
and the subsequent invasion of leukocytes into tissue are 
similar to events described in the CL during luteolysis (3). 
Structural regression of the CL 
Structural regression of the mammalian CL involves 
autophagy (cellular self-digestion) and/or heterophagy 
(removal of cells by macrophages) (56). Macrophages are 
abundant along the periphery and throughout the parenchyma of 
the regressing CL and are commonly observed phagocytizing and 
digesting material within the CL (56). Furthermore, the fully 
regressed CL exhibits a scar which consists of collagen and 
debris laden macrophages (56), 
The primary objective of this dissertation was to 
determine a possible role for macrophages in the CL of pigs. 
The next section describes the physiology of the macrophage 
and emphasizes functions of the macrophage which may be 
important in luteal function. 
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Physiology of the Macrophage 
Activities of macrophages are central to the initiation 
and maintenance of the effector phases of acute and chronic 
inflammation as well as wound healing (1). Through their 
secretion of cytokines, elements of the complement cascade, 
proteases, antiproteases and arachidonic acid metabolites, 
macrophages are important in the regulation of inflammation. 
As mediators of wound healing, macrophages serve as scavengers 
to remove both cellular and molecular debris (1). 
Macrophages are part of the mononuclear phagocyte system 
(MPS). They differentiate from stem cells in the bone marrow, 
circulate through the peripheral blood as monocytes and pass 
through blood vessel walls into peripheral tissue where they 
differentiate into mature macrophages (as reviewed by Adams 
and Hamilton; 1). Macrophages are capable of replicating in 
tissue, and often undergo further differentiation and 
maturation in tissue. Generally, development of new 
mononuclear phagocytes in sites of inflammation represent a 
combination of newly migrated young monocytes into the tissue 
and a local proliferation of the resident macrophage 
population (1). Central to the role of macrophage 
participation in inflammatory responses is the ability of 
these cells to congregate in areas of inflammation. 
Congregation is a complex process which is highly regulated 
under normal circumstance. It involves macrophage and 
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endothelial cell expression of surface integrins and adhesins, 
adherence to endothelium and directed migration of macrophages 
in response to a chemotactic stimuli. Often, the very act of 
macrophages migrating through endothelial cells into target 
tissue stimulates gene expression and cytokine production by 
these macrophages (29,30). 
Regulation of macrophage secretory activity 
Macrophages represent a highly heterogeneous cell 
population. They can express over 100 specific surface 
receptors and release over 100 defined molecular products (1). 
Release of products by macrophages is a complex process and 
the release of each product may be regulated independently. 
For example, some products such as lysozyme are apparently 
constitutively released, while most products are released 
following occupancy of a specific receptor or receptors on the 
plasma membrane of the macrophage (1). Since macrophages are 
widely heterogeneous both functionally and morphologically, 
examination of the morphology and phagocytic characteristics 
of a macrophage population has its limitations (15, 55). That 
is, at any particular time, the population of macrophages in a 
particular tissue will possess cells in different stages of 
maturation and activation and these macrophages will 
individually exhibit different functional and morphological 
characteristics. 
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It is generally accepted that the regulation of a 
macrophage response requires a cascade of events (1). These 
events include ligand-receptor interactions, generation of 
immediate second messengers, modulation of existing proteins 
(e.g., by phosphorylation or myristylation), modulation of 
gene expression, synthesis of new proteins and alteration in 
other cellular elements, such as glycolipids. In many cases, 
two signals are necessary to trigger release of cytokines or 
other products by macrophages. It is believed that the first 
signal acts as a priming signal to prepare the macrophage, 
while the second signal actually triggers the release of the 
product. Evidence to support the need for two signals 
includes the observations that basal metabolism of macrophages 
can be dramatically altered by ligand-receptor interactions, 
particularly those which initiate either phagocytosis or 
chemotaxis (30) and that lymphokines potentiate the secretion 
of several substances by macrophages (1). 
Many of the receptor-ligand interactions trigger 
macrophages to use NADPH+ and glucose to generate reactive 
oxygen species. An additional effect of receptor-ligand 
interactions is phospholipase A2-mediated release of 
arachidonic acid and its conversion to a series of 
leukotrienes or prostaglandins (1). 
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Macrophages as cytotoxic cells 
Target cells for macrophage destruction include 
prokaryotic organisms, normal cells, and tumor cells (1). 
Macrophages kill (cytolysis) their target by either antibody 
independent or antibody dependent pathways. Antibody 
independent cytolysis occurs when macrophages recognize the 
complement component C3b or altered membrane structures on the 
surface of the target cell (68) . Tumor cells, for example, 
are often killed by macrophages through antibody independent 
cytolysis. This type of cytolysis occurs in 1-3 days after 
cell-cell association, is contact-dependent, non-phagocytic 
and requires macrophages to be activated in a specific fashion 
(1). Macrophages kill by selectively capturing and binding to 
their target cell followed by a release of one of their toxic 
substances, (usually stored in granules) which results in the 
lysis of the cell. 
Antibody-dependent cellular cytotoxicity involves the 
destruction of target cells in the presence of specific 
antibodies. The macrophage recognizes the fraction 
crystallizable (Fc) portion of the antibody attached to an 
antigen on the surface of the target cell. Fc receptor-
mediated binding of target cells occurs readily and is 
complete within 5 minutes. However, the binding of thi 
antibody to the target is necessary, but not sufficient, for 
antibody dependent cellular cytotoxicity (ADCC). The second 
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step of ADCC involves the lysis of target cells through the 
release of mediators by macrophages after the cross-linking of 
the Fc receptor. The two main cytotoxic pathways resulting 
from macrophage activation are the superoxide pathway which 
results in production of reactive oxygen species and the L-
arginine dependent nitric oxide (NO) pathway which results in 
the production of reactive nitrogen intermediates (81). These 
pathways, in particular the formation of H2O2, are important 
for the completion of antibody dependent cytolysis (1). 
Oxygen metabolites, such as those produced by macrophages, are 
consistently identified as the most destructive toxins 
released from cells (89). 
Macrophages in wound healing 
"Macrophages play a pivotal role in the transition 
between inflammation and wound healing" (72) . In support of 
this statement, macrophages were shown to be rate-limiting 
effector cells in wound-healing by macrophage depletion 
studies (13). Moreover, macrophages are a key source of 
several cytokines and growth factors which appear to be 
involved in fibroplasia and angiogenesis (13). Their large 
repertoire of hydrolytic enzymes (12) such as collagenase, 
elastase and plasminogen activator gives the macrophage the 
capacity to degrade various materials rapidly. For example, 
collagenase and elastase act to degrade connective tissue 
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components while plasminogen activator will induce the 
formation of the fibrinolytic agent plasmin. Release of 
products by macrophages is regulated by their interaction with 
the extracellular matrix, serum components and exogenous 
agents (12,55). In this way, the microenvironment of the 
macrophage serves to regulate the maturation/activation of 
macrophages and provide a means for specific activity of the 
macrophage during inflammation and wound repair (12). 
Apoptosis or "programmed cell death" is common in not 
only the immune system, but also in endocrine tissue and has 
been described in the CL (69). Macrophages are the primary 
phagocytic cell that remove apoptotic cells and bodies (68). 
Macrophages that take up apoptotic cells do not release agents 
such as eicosanoids or cytokines (68,89). Thus, macrophage 
recognition of cells undergoing apoptosis is a swift, 
efficient way of removing unwanted cells from tissues and does 
not result in the release of products from macrophages that 
would alter the homeostasis of the tissue (68). 
Macrophages in reproductive associated tissues 
Macrophages have been identified in several reproductive 
associated tissues including the anterior and posterior 
pituitary, testis, uterus and ovary (31). These cells are 
found to line the vascular sinus and capillaries in these 
tissues and to exhibit typical macrophage morphology and 
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function (38). For instance, macrophages in the testis of the 
rat have Fc receptors, release superoxide anion and lysozyme, 
phagocytize and kill pathogenic bacteria, rapidly attach to 
plastic or glass surfaces and possess specific macrophage 
antigens (33) . 
In several animal models, the number of leukocytes have 
been shown to fluctuate during the lifespan of the CL. The 
most obvious change is an influx of leukocytes into the CL at 
the time of luteolysis. An influx of leukocytes at the time 
of luteolysis is consistent with a biological role for these 
cells in the luteolytic process. 
Leukocytes in the Corpus Luteum 
Macrophages 
Macrophages are present in the CL of virtually every 
species examined to date. Potential roles of macrophages in 
luteal function will be discussed in detail in the section 
titled "Macrophages in Corpora Lutea Regulation." 
Macrophages in luteinized tissue of laboratory animals. 
Bulmer (9) was the first to describe the presence of 
macrophages in ovarian tissue. He found that macrophages were 
particularly evident and numerous in ra. CL during the latter 
part of pregnancy and pseudopregnancy and in the early post­
partum period. At this time the macrophages were described as 
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"esterase-rich cells" with phagocytic properties. 
Brannstrom et ai. (8) used immunocytochemistry (ICC) to 
examine luteinized post-ovulatory follicles (LPF) of rats for 
different subsets of macrophages. Two different monoclonal 
antibodies were used to distinguish subsets of macrophages. 
One antibody was EDI, an antibody that labels a cytoplasmic 
antigen in 82-98% of the monocytes and macrophages present in 
tissue. The other antibody used was ED2, an antibody which 
labels a membrane antigen on tissue macrophages. There were 
fewer ED2 cells than EDI cells in the rat LPF. The authors 
interpreted their data as suggesting that the macrophage 
population in the LPF consists of a large population of newly 
recruited macrophages. 
Kirsch et al. (38) noted cells that had characteristic 
morphology of macrophages in luteal tissue from superovulated 
mice. These cells often made contact with steroidogenic cells 
and were perivascular. They were confirmed to be macrophages 
as they were highly phagocytic and non specific esterase 
positive. Kirsch et al. (38) suggested a stimulatory role for 
macrophages in progesterone production as macrophages were 
present when progesterone production by the LPF was maximal. 
In support of this hypothesis, these authors showed that co-
culture of peritoneal macrophages with dispersed luteinized 
cells significantly increased progesterone secretion (38). 
Hume et ai. (31) examined macrophage (termed mononuclear 
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phagocytes in this study) infiltration into LPF throughout the 
estrous cycle of the mouse. They found that macrophages were 
generally not present in follicles, yet rapidly entered into 
the developing LPF. These macrophages appeared to enter from 
the thecal layer and the site of follicular rupture. Once the 
structure of the LPF was established, macrophages lined the 
vascular sinuses. This morphology was maintained throughout 
diestrus, but by proestrus when luteolysis became evident, 
there was a substantial influx of macrophages. Furthermore, 
the degenerated LPF contained primarily macrophages. 
Paavola (57) not only determined the presence of 
macrophages in the guinea pig CL, but also examined if these 
cells were activated. Macrophages were considered to be 
activated if they exhibited one or more of the fine structural 
features generally regarded as characteristics of activation 
(proliferation of dense bodies, increase in cell size, 
evidence of augmented surface activity or endocytosis). 
Macrophages in CL collected from pregnant animals were usually 
smaller in size, contained fewer dense bodies, and showed 
fewer pseudopods than did macrophages from degenerating CL, 
indicating that the population of macrophages in the 
degenerating CL were more activated. These authors noted 
that, occasionally individual luteal cells were ingested by 
macrophages in pregnant animals. However, macrophage numbers 
appeared to be the greatest at the time of regression of the 
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CL and phagocytosis of luteal cells by macrophages increased 
markedly. Macrophages were noted to congregate at the 
periphery of regressing CL and, at the most advanced stage of 
luteolysis, macrophages enveloped virtually all luteal cells, 
most of which showed extensive deterioration. 
Baganvandoss et ai. (4) examined rabbit CL for 
macrophages and found only a few macrophages to be present on 
day 5 of pseudopregnancy. In contrast, numerous macrophages 
were present in the regressing rabbit CL removed on day 19 of 
pseudopregnancy or day 3 postpartum (5). The major influx of 
macrophages was seen at a stage the authors termed "terminal 
stages of regression" such as at the end of pseudopregnancy or 
several days after parturition. It is worthy to note that 
invasion of the CL by macrophages was delayed by pregnancy. 
By the day of parturition, however, macrophages did begin to 
infiltrate the CL, presumably in association with luteolysis. 
Recently Seiner et ai. (71) used an anti-inflammatory 
drug, methylprednisolone, to determine whether 
immunosuppression would alter the luteal phase of the 
pseudopregnant rabbit. They found that this treatment 
significantly decreased the number of macrophages and 
virtually eliminated T lymphocytes in the CL at luteolysis. 
However, this treatment aid not prevent the decline in 
progesterone or inhibit structural luteolysis. Not 
withstanding the possibility that large doses of 
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glucocorticoids may directly induce luteolysis, this 
experiment profoundly weakens the hypothesis that leukocytes 
are involved in the luteolytic process. 
Macrophages in human CL. Wang et al. (87) found 
macrophages were the single most abundant leukocyte in the 
human CL, comprising up to 10% of the total population of 
cells. Macrophages were often in contact with luteal cells. 
The antigen CD14 is highly expressed on mature blood 
monocytes and macrophages, is perhaps one of the most specific 
antigens for the monocytic lineage, and is a receptor for 
lipopolysaccharide (55). Petrovska et ai. (59) examined human 
CL for the presence of CD14+ macrophages (CD=cluster of 
differentiation) using ICC. These macrophages were most 
abundant in the fibrous trabeculae, stroma, and theca lutein 
trabeculae of the CL, but were rare in the granulosa lutein 
layer in the young CL. The pattern of distribution of CD14+ 
macrophages within the CL was similar at a time of maximal 
endocrine activity (days 7-9 of the menstrual cycle) and at 
structural regression (days 10-14 of the menstrual cycle) 
which suggests that CD14+ macrophages do not play a role in 
the maintenance of luteal lifespan. 
Katabuchi et ai. (36) found that macrophages . icreased in 
number at the time of luteinization of the human post 
ovulatory follicle. Macrophages were common in capillaries, 
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especially capillaries on the periphery of the CL. In the 
mature CL, macrophages exhibited many electron-dense 
lysosomal granules and phagocytic vacuoles. At the time of 
luteal regression macrophages contained abundant lipid 
droplets and cholesterol crystals suggesting a role for these 
macrophages in the phagocytosis and degradation of 
degenerating luteal cells. In support of this hypothesis, the 
authors noted that phagocytosis of luteal cells was "the most 
recognized phagocytic property of macrophages in the ovary." 
The antigen CD68 is a 110 kDa glycoprotein found within 
the cytoplasm and lysosomal granules of macrophages. A study 
by Lei et al. (42) confirmed that CD68+ macrophages 
significantly increased in numbers (twofold) from early to mid 
luteal phases and from mid to late luteal phases of the 
menstrual cycle in human. In this study, stages of CL were 
determined by the menstrual history of the donor and/or by the 
morphology of the CL. In the early and mid-luteal phase, 
macrophages were scattered in increasing numbers among luteal 
cells. In the late luteal phase, macrophages greatly 
increased in number and were most concentrated in the 
periphery of the CL. 
Macrophages in ruminant CL. In cows (43) during 
structural luteolysis (as determined by degeneration of 
endothelial cells of the CL) macrophages exhibited strong acid 
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phosphatase activity and were prominent among luteal cells. 
Sheep CL examined during PGF-induced luteolysis exhibited 
abundant macrophages at a time (8 hours) when extensive 
changes in the integrity of the luteal tissue was apparent 
(49). At this time, cellular fragmentation and debris were 
detected, capillaries appeared to be constricted and there was 
evidence of vascular damage. Eosinophils were present in CL 
by 2 hours after PGF administration, and prior to the noted 
macrophage infiltration. Eosinophil peroxidase augments the 
ability of macrophages to phagocytize tumor cells, and Murdoch 
(49) suggested that a similar mechanism may exist for 
resorption of luteal cells. 
Macrophages in pig CL. A morphological examination 
for the presence of leukocytes in the pig preovulatory 
follicles, corpus hemorrhagicum, or CL was accomplished by 
examining tissue that had been stained with hematoxylin, 
eosin, and Giemsa stains (73). The age of the CL were 
determined by gross morphology of the CL and progesterone 
concentrations of CL were not determined. Macrophages 
accounted for 30-43% of all leukocytes in all stages of the 
estrous cycle. Absolute numbers of macrophages increased 
almost fourfold in the corpus hemorrhagicum (day 0-1) compared 
to the preovulatory follicle (day -2 to -1). In the mature 
CL, macrophage numbers decreased to preovulatory follicle 
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levels. In the regressing CL (days 16-19), however, 
macrophage numbers again increased and were similar to the 
number of macrophages noted in the corpus hemorrhagicum. 
T lymphocytes 
T lymphocytes represent a group of cells that play an 
essential role in the immune response. In general, mature T 
lymphocytes can be divided into two groups, CD4+ and CD8+. 
CD4+ T lymphocytes, also called T helper cells, are important 
in the humoral immune response. That is, they recognize 
antigen presented to them by an antigen presenting cell in the 
cleft of a major histocompatibility complex class-II (MHCII) 
molecule. Antigen associated with MHCII is the result of the 
endocytic pathway of antigen processing cells (51). In 
response to this recognition of antigen plus MHCII, CD4+ T 
lymphocytes produce lymphokines that are important in a B cell 
(antibody producing cell) response and in activation of 
leukocytes in cell-mediated immunity. In contrast, CD8+ T 
lymphocytes, also called T cytotoxic/suppressor cells, 
recognize antigen in the cleft of major histocompatibility 
complex-I (MHCI). Major histocompatibility complex-I is 
present on virtually all nucleated cells of the body and 
antigen presented by MHCI is generally the result of 
intracellular breakdown of products within the presenting cell 
(51). One subset of CD8+ T lymphocytes are T suppressor 
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lymphocytes. These lymphocytes act to regulate (usually in a 
suppressive manner) the immune response. Another subset of 
CD8+ T lymphocytes, T cytotoxic (Tc) lymphocytes, possess the 
capability of killing cells which are recognized as foreign to 
the body. The exact mechanism of killing by Tc lymphocytes is 
unclear, but is believed to occur through the release of one 
or more lytic substance(s) (e.g., perforin, serine esterase, 
granzyme) by the Tc lymphocyte. Additionally, cytokines from 
both CD4+ and CD8+ T lymphocytes play roles in chemotaxis and 
activation of several different leukocytes (including 
macrophages). T lymphocytes are present in the CL in a number 
of species. As the activity of T lymphocytes is largely 
dependent on the presence of MHC molecules, the presence of T 
lymphocytes and MHC molecules within luteal tissue will be 
discussed in the following sections. 
T lymphocytes and MHC expression in luteinized tissue of 
laboratory animals. T lymphocytes were identified in day 5 
pseudopregnant CL of rabbits (4) preceding the appearance of 
macrophages. T lymphocytes were present in lower numbers than 
either macrophages or neutrophils in LPF of rats (8). Most of 
the T lymphocytes present in rat LPF were CD8+ (80%) and these 
cells appeared to be recruited into the LPF as luteinization 
progressed. Brannstrom et ai. (8) suggested a selective 
ovarian infiltration of CD8+ T lymphocytes as the peripheral 
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blood ratio of CD4+;CD8+ T lymphocytes is about 2. They 
further suggested that one possible action of CD8+ T 
lymphocytes is the release of interleukin-2 (IL-2) which may 
act to suppress progesterone release (functional luteolysis). 
In support of this hypothesis, IL-2 has an antigonadotropic 
action on progesterone secretion in human granulosa/lutein 
cells (86). 
T lymphocytes and MHC expression in human CL. Wang et 
al. (87) detected both CD8+ and CD4+ T lymphocytes in human 
CL. These authors determined that many of these lymphocytes 
possessed IL-2 receptors. They suggested that these 
lymphocytes were activated as IL-2 receptor expression is an 
indication of lymphocyte activation. The predominant sites of 
T lymphocytes were in the theca-luteal and the loose 
connective tissue areas of the CL and not the granulosa-luteal 
areas. 
Petrovska et ai. (59) studied the distribution of T 
lymphocytes in young CL (days 1-6 of the menstrual cycle), CL 
during maximum endocrine activity (days 7-9) and in the 
regressing CL of humans. T lymphocytes were not observed in 
young CL. During maximum endocrine activity, CL possessed T 
lymphocytes that were most concentrated in the theca lutein 
trabeculae. The distribution of T lymphocytes in the CL did 
not change between the time of maximal endocrine secretion and 
31 
regression. These authors hypothesized that T lymphocytes do 
not play a role in attracting macrophages into the human CL as 
they were limited in number in the CL. 
The expression of MHCII in the CL was also examined using 
ICC by Petrovska et al. (59). Major histocompatibility 
complex-II positive cells of CL increased 3-4 fold during 
maximal endocrine activity when compared to the day 1-6 CL. 
Major histocompatibility complex-II positive cells were more 
frequent in both the granulosa-luteal layer and theca lutein 
trabeculae during maximal endocrine activity while the central 
cavity of the CL had few MHCII cells. Petrovska et ai. 
established that, macrophages and other MHCII positive cells 
were the most prominent "immune cell" in the human CL 
throughout its lifetime. 
T lymphocytes in ruminant CL. On day 14 of the 
estrous cycle in the cow (43), many lymphocytes were noted in 
blood vessels of the CL and tissue associated with these 
vessels. By day 15, 16 and 17, there was a more prominent 
infiltration of lymphocytes into the CL. 
Fairchild and Pate (17) showed that there was an up-
regulation/alteration of luteal MHCI and MHCII expression on 
bovine luteal cells after treatment with interferon-y (IFNy). 
These authors suggested that an increase in MHCI could serve 
as a means of recognition of luteal cells by Tc lymphocytes 
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and thus allow cytotoxicity of luteal cells. They further 
suggested that an increase in MHCII on luteal cells would 
increase antigen presentation properties of luteal cells and 
possibly stimulate a reaction in the CL similar to an 
autoimmune disease. 
T lymphocytes in pig CL. Pig CL (73) at different 
stages were examined for lymphocytes using differential stains 
hematoxylin, eosin and Giemsa. The absolute number of 
lymphocytes (B and T cells cannot be differentiated by 
morphology alone) increased tenfold in tissue shortly after 
ovulation as compared to preovulatory follicle levels. 
Lymphocytes increased threefold and remained as one of the 
predominant cell types in the developing CL (day 2-7). 
However, lymphocyte numbers declined after day 7 of the 
estrous cycle and numbers were similar to those found in the 
preovulatory follicle. 
Eosinophils 
Eosinophils are polymorphonuclear leukocytes with a 
capacity to release several products into their environment. 
Eosinophils can potentially damage cells by various mechanisms 
as several secretory products of eosinophils are cytotoxic 
(49). For instance, eosinophil cationic proteins can act to 
form pores in membranes. Major basic protein and protein X 
also promote cellular injury. Eosinophil peroxidases catalyze 
the generation of highly toxic oxidants and peroxidation of 
lipids which could result in significantly altered membrane 
fluidity, calcium ion influx and disruption of enzymatic 
systems, such as Na+-K+-ATPase. Additionally, eosinophil 
peroxidases enhance macrophage mediated killing of tumor cells 
(49) . 
Eosinophils in ruminant CL. An eosinophil 
infiltration in the CL of sheep has been reported by Murdoch 
(49). The number of eosinophils counted within the CL 
increased 2 hours after PGF treatment, remained elevated to 4 
hours after PGF treatment and declined by 8 hours. 
Eosinophils were especially prominent along connective tissue 
trabeculae and in association with blood vessels. An 
important observation is that eosinophils were present by 2 
hours after PGF administration and prior to functional 
regression of the CL (as determined by serum progesterone 
concentrations) which was not detected until 8 hours. This 
observation suggests that eosinophils play a role in the 
induction of luteolysis. 
Murdoch (49) also examined the ability of luteal tissue 
to attract eosinophils (chemotaxis). Briefly; slices of CL 
which were treated with either PGF or left untreated were 
placed in wells of an agarose gel. Peripheral blood 
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leukocytes were added to an adjacent well and the migration of 
eosinophils towards the luteal samples was measured. In 
addition, the ability of PGF alone (no luteal cells) to 
attract eosinophils was measured. Eosinophils were not 
attracted to PGF alone or to untreated (no PGF) slices of CL. 
Eosinophils were attracted to CL that had been treated with 
PGF. On the basis of these results, it appears treatment of 
CL with PGF induces the production of a chemotactic factor for 
eosinophils. 
Murdoch and Steadman (50) treated ewes with prednisolone 
and prevented the eosinophilia characteristic of regressing 
CL. However, the prevention of eosinophilia did not affect 
the ability of PGF to cause functional or structural 
luteolysis in ewes. These data provide strong evidence that 
eosinophils are not essential for luteal regression to occur 
in sheep. 
Eosinophils in porcine CL. Eosinophils (73) were 
present in significant numbers in the preovulatory follicle 
and the corpus hemorrhagicum (day 0-1) of the pig. They 
decreased to very low numbers in developing (day 2-7) and 
mature CL (day 8-15) as determined by hematoxylin, eosin and 
Giemiia staining. However, there was a dramatic influx of 
eosinophils into the regressing CL (day 16-19) and eosinophils 
were abundant in the thecal tissue of regressing CL. 
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Eosinophils were also found to be concentrated in the center 
of the regressing CL. 
Neutrophils 
Neutrophils are polymorphonuclear leukocytes which have a 
primary function of monitoring the body for foreign substances 
and eliminating these substances by phagocytosis. Neutrophils 
are important cells for immune surveillance as they make up 
80% of the leukocyte population (89). Neutrophils possess 
three types of secretory granules and, like macrophages, have 
a high secretory capacity. Neutrophils kill target cells 
through the release of reactive oxygen species (such as H2O2) 
and other substances such as lysozyme, cationic proteins, 
lactoferrin, proteolytic enzymes and hydrolytic enzymes (90). 
They are the first phagocytic cells present in an inflammatory 
response, yet, their presence is usually short-lived and they 
are soon replaced by macrophages. Although the functions of 
neutrophils and macrophages are similar in many ways, very few 
studies examined the presence of neutrophils in CL at the time 
of regression. 
Neutrophils in laboratory animal CL. Riley and 
Behrman (63) detected HgOg in luteal tissue of pseudopregnant 
rats. These authors suggested that neutrophils are the source 
of H2O2 in the CL (58). 
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Neutrophils in pig CL. Neutrophils made up 12-20% of 
the leukocytes found in the preovulatory follicle, corpus 
hemorrhagicum, and CL. Neutrophils were the third most 
abundant leukocyte noted in the regressing CL of pigs (day 16-
19) (73). 
B cells, plasma cells, basophils and mast cells 
B cells are important in the humoral immune response as 
they possess immunoglobulin on their surface. In response to 
an antigen and proper stimulation (by T lymphocytes) B cells 
will proliferate and produce antibody. At this stage they are 
called plasma cells. 
Basophils are the circulatory counterpart of mast cells. 
Mast cells have specialized receptors for immunoglobulin E and 
play a primary role in allergy when they degranulate and 
release histamine. 
B cells, plasma cells, basophils and mast cells are rare 
in the CL. For example, no B cells were found in the human CL 
(87). Additionally, the absolute number of plasma cells 
remained low in pig CL (73) and were not significantly 
different throughout all stages of the estrous cycle (less 
than 7% of all leukocytes). Moreover, there was an absence of 
basophils and mast cells in pig CL (73) . 
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Macrophages in corpora Lutea Regulation 
The multiple functions of macrophages and the presence of 
macrophages in the CL are consistent with a potential role of 
this cell type in luteal function. Macrophages could have a 
role in the regulation of steroidogenesis through their 
secretion of products that regulate growth and/or 
differentiation of cells. In addition, macrophages through 
their cytotoxic activity, could act to bring about the death 
of the cells of the CL. In contrast, macrophages may act in a 
manner similar to wound healing to clear cellular debris and 
encourage new cell growth after luteolysis has occurred. 
Regulation of steroidogenesis by macrophages 
Macrophages possess enzymes that may be relevant to the 
secretion of steroid hormones. For example, macrophages can 
metabolize androstenedione to testosterone and its 5a reduced 
metabolites (31). Moreover, macrophages possess the enzyme 
2 0a-hydroxysteroid dehydrogenase which catalyzes the 
conversion of pregnenolone, progesterone and 17a-0H 
progesterone into their respective 20a-derivatives (45). 
Several studies have proposed a role for macrophages in 
ovarian steroidogenesis especially in the regulation of 
progesterone production by granulosa or luteal cells. For 
example, when peritoneal macrophages or peripheral blood 
monocytes were co-cultured with human granulosa cells. 
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progesterone accumulation increased by 160-3 00% (27). 
Additionally, when macrophages (termed mononuclear phagocytes 
in this study) from mice LPF were in close proximity to luteal 
cells in vitro progestin production by luteal cells was 
enhanced (38). These resident LPF macrophages were more 
effective in stimulating progesterone production from luteal 
cells than were peritoneal macrophages (38). 
The act of migration of macrophages into target tissue 
can induce a release of specific cytokines. For example, 
engagement of the ligands CD44 (a ligand for a cartilage 
linked protein), CD45 (a cell surface tyrosine kinase found on 
all hemopoietic cell), LFA-3 (LFA=lymphocyte function 
associated antigen, a ligand for CD2), and VLA-4 (VLA=very 
late antigen, a receptor for the extracellular matrix 
component fibronectin and activated endothelial cell marker 
VCAM-1) on the surface of macrophages triggers tumor necrosis 
factor (TNF) and interleukin-1 (IL-1) release (88,96). These 
two cytokines, in addition to other products of macrophages, 
(2) such as transforming growth factor-6, IFN-y, fibroblast 
growth factor (FGF), insulin-like growth factor-1 (IGF-l), and 
platelet derived growth factor have been confirmed by in vitro 
studies to act directly on granulosa cells (precursors of 
luteal cells) oi different species to regulate progesterone 
synthesis (28,69). For instance, IL-1 inhibits basal and LH-
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stimulated progesterone production by granulosa cells (21,23) 
possibly by decreasing cAMP (22). 
Finally, a product of macrophages, increases in 
rat CL at early stages of PGF-induced luteolysis (63). 
Hydrogen peroxide has an acute antigonadotropic action on LH-
receptor coupling and subsequent progesterone synthesis by rat 
luteal cells (58). 
Effects of steroids on macrophage function 
Several studies support the hypothesis that macrophage 
activity can be influenced by hormones (especially steroids). 
For example, the cytokine repertoire of macrophages can be 
regulated by steroid hormones (83) . Additionally, steroids 
have profound effects on other macrophage functions such as 
phagocytosis. The regulation of macrophage activity by 
steroids may be crucial in luteal physiology. 
Evidence for the effects of steroids on macrophage 
activity include the observation that estrogen and 
progesterone treatment of mouse peritoneal macrophages in 
vitro (as reviewed by Mori; 48) induces an increase in IL-1 
secretion. Furthermore, exposure of human peripheral 
monocytes to low concentrations of both estrogen and 
progesterone results in maximal IL-1 activity (61) . Yet, 
treatment with higher concentrations of estrogen and 
progesterone result in a significant reduction in IL-1 
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activity. In vivo data which support the importance of 
steroids on IL-1 concentrations (potentially produced by 
macrophages) include the observation that there is a 
significant increase in IL-1 concentrations in the blood of 
women during the luteal phase of the estrous cycle (10). 
Estrogen and progesterone also have an effect on the 
production of other cytokines by macrophages. For example, 
physiological levels of estrogen and progesterone will 
decrease TNF mRNA production by monocytes from humans (44). 
Moreover, TNF is undetectable in unstimulated luteal phase 
monocytes in humans (44). 
Multiple effects of estrogen and progesterone on 
macrophage function have been described. For instance, 
estrogens are reported to be the most powerful naturally 
occurring stimulants of macrophage phagocytic activity (83). 
Moreover, both progesterone and estrogen inhibit cytotoxic 
activity of peripheral blood monocytes (18) and together they 
have a synergistic effect. Estrogen and progesterone have an 
inhibitory effect on the production of collagenase by 
macrophages (85). Coincidently, estradiol at doses used to 
inhibit collagen breakdown in the uterus, inhibits the influx 
of macrophages and eosinophils into this tissue (93). 
Furthermore, studies by Tansey and Padykula (75) indicate that 
progesterone acts to inhibit the conversion of monocytes or 
macrophages in the involuting rat uterus. 
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Estrogen and progesterone are not the only ovarian 
hormones potentially important in the regulation of macrophage 
functions. Products of arachidonic acid metabolism are also 
important regulators of macrophage activity (53). For example 
prostaglandin-E has profound inhibitory effects on the release 
of lysosomal hydrolase in human macrophages. Prostaglandin-E 
also effects macrophage locomotion, shape change, and 
phagocytosis (7). 
Tissue removal, repair or replacement by macrophages 
The regression of the CL (structural luteolysis) occurs 
rapidly. Not only does the weight of the CL decline 
dramatically during luteolysis (20), but luteal cells and 
vascular components are replaced by connective tissue within a 
matter of days (11). Macrophages may play an important role 
structural luteolysis. For example, macrophages synthesize 
and secrete collagenase and elastase, enzymes that play a role 
in tissue destruction. Moreover, macrophages release 
substances that induce neovascularization and fibroblast 
proliferation. Fibroblasts are cells which are essential in 
wound healing because of their ability to proliferate locally 
and lay down extracellular matrix components such as collagen, 
ihe macrophage may, therefore, initiate the sequence of events 
which result in the removal and replacement of tissue in the 
CL during luteolysis. In support of this hypothesis, the 
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morphology of the fully regressed guinea pig CL has been 
described as a scar consisting of collagen, debris-laden 
macrophages, a few fibroblasts and some cells that resembled 
luteal cells (56). 
Macrophages through their secretion of TNF could destroy 
endothelial cells as these cells possess TNF receptors (83) . 
Specific effects of TNF will be discussed in detail in the 
Tumor Necrosis Factor section of this dissertation. 
Macrophages possess a wide array of neutral proteinases 
and aminopeptidases, which may participate in extracellular 
processing of peptide hormones or growth factors important in 
luteal tissue turnover (1). Furthermore, macrophages are 
major secretors of E-type prostaglandins. Prostaglandins 
produced by macrophages stimulate the production of several 
important mediators of T lymphocytes and the release of 
collagenase from other macrophages which may play an important 
role in structural luteolysis of the CL in a manner similar to 
wound healing (53). 
As already mentioned, macrophages are crucial in wound 
healing through their role of debris removal and enhancement 
of fibroblast growth (72). As a rapid turnover of tissue is 
necessary in regression of the CL, macrophages may play an 
essential role in this pr. cess. Macrophages can be activated 
to produce products which degrade fibrin (1). In addition, 
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macrophages will produce angiogenic factors in the presence of 
cellular debris. 
Macrophages are the primary phagocytic cells that remove 
apoptotic cells and bodies (68) and macrophages appear to be 
involved in structural disintegration of the CL (9) through 
the removal of the debris of the regressing CL (36,38,56,57). 
Sawyer et ai., (69) determined that endothelial cells of 
regressing CL are deleted by apoptosis. Additionally, 
apoptosis is confirmed to occur in the regression of cow CL 
(35). Macrophages engulf apoptotic bodies and luteal cells of 
guinea pig CL (3,57). 
Both IL-1 and TNF are primary products of macrophages 
(81). Evidence exists for the presence of TNF in the CL of 
several species (4,64,65) and for this cytokine to be present 
at the time of luteolysis in the rabbit (4). An additional 
objective of this dissertation, therefore, was to identify TNF 
in luteal tissue of pigs. Various aspects of TNF and 
potential roles of this cytokine in luteal function will be 
discussed in the following section. 
Tumor Necrosis Factor 
Tumor necrosis factor is now considered to be 
one of the most multifunctional response 
modifiers in inflammatory processes and 
immunological reactions, to have growth factor 
activity on some cell types and to induce 
expression of adhesion or histocompatibility 
molecules on others (Rothe et ai.; 66). 
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A primary product of macrophages is a 17 kDa protein, 
tumor necrosis factor-a (TNFa) . Macrophages also produce a 
related factor TNF& which shares the same receptors with TNFa 
(81) . Most studies do not distinguish between TNFa and TNF13, 
therefore data described in this section will consider these 
two proteins as one (TNF). 
Specific activities of TNF include cytotoxicity, cell damage, 
cell protection (from oxidative injuries), cell 
differentiation and tissue development (81). 
The biologically active form of TNF is believed to be a 
trimer (66) of the 17 kDa protein. A 28 kDa membrane form of 
TNF was shown to exist on macrophages and has been proposed to 
be the precursor of all soluble TNF. Vassalli (81), however, 
suggested that the membrane TNF may exist in vivo only on 
strongly stimulated tissue macrophages. Tumor necrosis factor 
is produced by other leukocytes besides macrophages such as 
monocytes (a precursor of macrophages), neutrophils, natural 
killer cells (NK cells), mast cells and lymphocytes (6,80). 
Additionally, endothelial cells, keratinocytes, microglial 
cells, smooth muscle cells, intestinal paneth cells, tumor 
cells, embryos and ovarian cells all can be a source of TNF 
(66,81). From these data, it is clear that the cells which 
serve as a source of TNF are diverse and often highly 
specialized (81). 
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Targets for TNF 
Potentially any nucleated cell can be a target for the 
action of TNF as virtually all types of nucleated cells have 
receptors for TNF (81). Two different receptors for TNF 
exist, TNF receptor-1 (Rl; 55 kDa) and TNF receptor-2 (R2; 75 
kDa). These receptors differ in size and, more significantly, 
in their transmembrane and intracytoplasmic domain. Both 
receptors are believed to be active in signal transduction 
(40,91). However, each of these receptors has unique 
signalling pathways (40). Vassalli suggested that the two TNF 
receptors exist and have different functions in order to 
amplify the range of action of TNF (81). Some cells bear both 
types of receptors (endothelial cells and NK cells) while most 
cells have only one type of receptor. Cellular responses 
ascribed to TNF-Rl include induction of NFkfi, accumulation of 
c-fos, IL-6 and manganese-dependent superoxide dismutase mRNA, 
prostaglandin E2 synthesis, enhanced IL-2 receptor and MHC I 
and II expression, growth inhibition and cytotoxicity (76). 
Tumor necrosis factor-Rl almost exclusively (compared to TNF-
R2) regulates expression of adhesion molecules on endothelial 
cells which are important for leukocyte migration into target 
tissue (39). The primary activity of TNF-R2 is the mediation 
of prolifer ition of thymocytes and T cell lines (as reviewed 
by Tartaglia and Goeddel; 76). At low concentrations, TNF 
would preferentially bind to TNF-R2 as it has a higher 
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affinity for TNF compared to TNF-Rl (76). Cross linking of 
the TNF receptor is believed to be important for cell 
signalling which is consistent with the observations that the 
biologically active form of TNF is a trimer and that TNF 
induces the aggregation of the extracellular domain of TNF-Rl 
in solution (76). 
Identification of Tumor Necrosis Factor in the Corpus Luteum 
The presence of TNF in luteal tissue was first described 
in the rabbit (4). In this study, conditioned media from day 
5, 17 or 19 pseudopregnant rabbit CL were examined for TNF 
activity. When day 17 and 19 CL were cultured in the presence 
of LPS, TNF activity was noted. As LPS is a powerful inducer 
of TNF secretion by macrophages (81), and pseudopregnant 
rabbit CL have a high number of macrophages on days 17 and 19 
(5), it is likely that the cell source of TNF in rabbit CL 
were macrophages. 
In cow, TNF was most prominent in the thecal cords 
radiating into the center of the CL from the periphery. Using 
ICC a few cells were found to be slightly reactive with the 
TNF antibody and these cells were distributed throughout the 
CL in relatively low numbers compared to the TNF positive 
cells of the thecal cords (64). Alternating ICC sections of 
cow CL, stained for TNF and macrophages revealed TNF in cells 
identified as macrophages. An additional population of TNF 
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positive cells were sparsely located throughout the 
interstitium of the CL. Roby and Terranova (64) described 
these cells as relatively large and polyhedral shaped and 
suggested that they were macrophages (64). 
Roby et al. (65) have also detected TNF in large luteal 
cell and the paraluteal cells of human CL using ICC. Tumor 
necrosis factor was determined to be located throughout the 
cytoplasm in the small paraluteal cells. Moreover, mRNA for 
TNF in tissue samples from rat ovaries at unknown stages of 
the estrous cycle has been confirmed by northern blot analysis 
(67) . 
Potential roles of Tumor Necrosis Factor in the Corpus Luteim 
Tumor necrosis factor in the CL could regulate 
steroidogenesis by luteal cells, act as a cytotoxic substance 
to destroy luteal cells, and/or act as a factor for cellular 
renewal and tissue homeostasis. 
Effects of TNF on steroidogenesis 
Most of the experimental systems used to analyze the role 
of TNF in ovarian tissue have been in vitro examinations of 
the effects of TNF exposure on granulosa cells collected from 
follicles of several species. While follicular granulosa 
cells are different from luteal cells in many ways, it is 
generally accepted that granulosa cells are the precursor for 
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large luteal cells (28), the major source of progesterone in 
the CL. Thus, the effect of TNF on granulosa cell 
steroidogenesis may be relevant to luteal function and will be 
discussed briefly. Studies which examine the effect of TNF on 
pig granulosa or luteal cells in vitro will be discussed in 
more detail. 
Data from in vitro experiments examining the effect of 
TNF on ovarian tissue are often conflicting and vary from 
species to species. In some systems, such as in mouse and 
human granulosa cell culture, TNF stimulates production of 
progesterone (97). In contrast, TNF inhibits gonadotropin-
stimulated accumulation of progesterone in pig granulosa cells 
(82) . 
Vehdhuis et al. (82) examined the effect of TNF on 
porcine granulosa cells and showed that recombinant human TNF 
(at ng/ml concentrations) inhibited the stimulatory effects of 
insulin, insulin combined with FSH, forskolin, cholera toxin, 
and 8-bromo-cAMP on progesterone accumulation by granulosa 
cells (82). These authors suggested that the effect of TNF is 
at the level of cholesterol side chain cleavage activity as 
there was sufficient soluble sterol substrate available in 
their culture system yet, progesterone accumulation did not 
occur. In support of this hypothesis, TNF diminished the 
stimulatory effect of FSH and insulin on porcine granulosa 
cell P450 side chain cleavage mRNA production (82). 
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Recently Tekpetcy et al. (77) examined the effects of TNF 
on pig thecal, granulosa and luteal steroidogenesis using in 
vitro cultures. Tumor necrosis factor decreased cAMP 
stimulated accumulation of progesterone in thecal cultures, 
but did not have an effect on FSH-stimulated accumulation of 
progesterone by pig thecal or granulosa cells. Tumor necrosis 
factor decreased LH-stimulated accumulation of progesterone in 
thecal and granulosa cell cultures. However, and more 
pertinent to CL function, TNF did not affect LH-stimulated 
progesterone accumulation in fractions of either small or 
large luteal cells collected from pigs on days 10-14 of the 
estrous cycle. 
Effects of steroids on TNF activity 
If indeed TNF were to play a significant role in luteal 
function, the regulation of TNF expression by hormones might 
be important. There is evidence that such regulation exists. 
In the mouse uterus, TNF (as measured by ICC and a bioassay) 
increases as the animal nears proestrus and TNF expression is 
highest during estrus. Moreover, when both estrogen and 
progesterone were given to ovariectomized mice TNF mRNA 
expression in the mouse uterus was induced (14). Treatment of 
human luteal phase monocytes with Tamoxifen (an estrogen 
antagonist) at levels equivalent to 10"^ or 10"^ M of estrogen 
resulted in decreased TNF mRNA expression. Similarly, 
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treatment of human luteal phase monocytes with RU 486 (a 
progesterone antagonist) also decreased TNF mRNA expression 
(44). Moreover, FSH induces a significant enhancement in TNF 
production in granulosa cells from follicles of superovulated 
women (97) . These data, therefore, suggest that TNF present 
in the CL potentially plays an important role in luteal 
function and that the activity of this cytokine in the CL may 
be regulated by the hormonal status of the animal. 
Cell cytotoxicity by TNF 
An additional mechanism of TNF action could be 
cytotoxicity of cells of the CL, especially endothelial cells. 
Tumor necrosis factor induces marked morphological changes in 
endothelial cell shape and inhibits endothelial cell 
proliferation (81), potentially by a reduction of receptors 
for growth factors (16). Additionally, TNF increases the 
susceptibility of endothelial cells to injury by activated 
polymorphonuclear leukocytes (16) . 
Early events of TNF cytotoxicity include a functional 
damage of selective components of the mitochondrial electron 
transport chain and structural alterations in mitochondrial 
morphology. There is also an elevation of cytoplasmic calcium 
from intracellular stores and subsequent activation of 
proteases and phospholipases which are important in TNF 
cytotoxicity (34). The effects of TNF on cells including the 
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increase in intracellular calcium and phospholipase A2, are 
similar to the effects of PGF on luteal cells (92). 
Other events signalled by TNF which could be important in 
the cytotoxic activity of TNF include G-protein coupled 
activation of phospholipases, generation of oxygen radicals, 
and DNA damage. Recently it was suggested that superoxide 
radicals or other reactive oxygen species participate in TNF-
initiated cytotoxicity (70) . In support of this hypothesis is 
the observation that tumor cells are susceptible to TNF 
cytotoxic activity and tumor cells generally contain low 
levels of enzymes that act to decrease oxygen radicals and 
HgOg (70) . 
The presence of TNF is usually closely linked to an 
immune response. Tumor necrosis factor will increase cytokine 
and adhesion molecule expression by leukocytes which are 
important in activation and chemotaxis of leukocytes (34). 
For example, TNF induces rapid adhesion of neutrophils and 
eosinophils to monolayers of endothelial cells which are 
subsequently damaged. Tumor necrosis factor enhances 
phagocytosis, induces degranulation and stimulates the 
generation of superoxides by neutrophils (10). In the 
presence of IL-2, TNF increases the expression of IL-2 
receptors and cytotoxic activity of NK and lymphokine 
activated killer cells. Furthermore, TNF exerts its effects 
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by stimulating activation and differentiation of monocytes and 
macrophages (81). 
Effect of TNF on tissue renewal 
As a rule, TNF is not toxic to most normal cells (81). 
For instance, Hunt et al. (32) found TNF mRNA and protein in a 
number of different tissues of mice in the absence of 
pathological conditions. Furthermore, many actions of TNF are 
consistent with renewal and/or restructuring of tissue. Tumor 
necrosis factor strongly promotes tissue factor-like 
procoagulant activity and suppresses endothelial cell surface 
anticoagulant activity. Tumor necrosis factor has a powerful 
antifibrinolytic action as it decreases the production of 
plasminogen activators and increases the production of 
plasminogen activator inhibitor-I. The overall effect of TNF 
is a strong clot promoting activity, which is observed in vivo 
after TNF injection in humans (81). In addition, TNF appears 
to inhibit collagen synthesis by fibroblasts, to suppress 
type-I-collagen gene expression (81) and to stimulate 
collagenase production (64). These activities may be 
important in the breakdown of basement membranes (64). 
Tumor necrosis factor regulates the expression of 
proteins in normal (84) and transformed cells. It activates 
at least two families of transcriptional factors: AP-1 and 
NFkli. In human fibroblasts, TNF causes transcriptional 
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activation of c-fos and c-jun. Tumor necrosis factor 
stimulates phosphorylation of a capping protein. All of these 
activities suggest a role for TNF in the regulation of protein 
synthesis. 
Activities ascribed to TNF could be important in the 
regulation of protein synthesis by cells which make up the CL. 
Proteins produced by cells of the CL may include growth 
factors or cytokines which may be important in luteal 
function. For example, TNF induces IL-1 and IL-6 production 
by endothelial cells (47) and exposure of fibroblasts to TNF 
results in the production of numerous cytokines and growth by 
these fibroblast (81). Moreover, prolonged infusion of TNF 
into tissue results in a dense accumulation of fibroblasts 
within a few days accompanied by neoangiogenesis and epidermal 
hyperplasia that is similar to wound healing (81). Tumor 
necrosis factor stimulates the proliferation of ovarian 
epithelial cells which has important implications in not only 
normal ovarian "growth" but also abnormal growth as in ovarian 
cancer (95). 
From these data, one could envision TNF acting throughout 
the luteolytic process. Roby and Terranova (64) suggested the 
following scenario for the role of TNF in the CL; TNF would 
alter the steroidogenesis of lut<.al cells and at the same time 
retard and/or inhibit growth of endothelial cells and increase 
leukocyte activity. Small vessels might thus become blocked 
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with cellular debris, disrupting the blood supply to the CL 
which would result in regression of the CL (64). 
In fact, changes observed in endothelial cells during 
luteal regression include nuclear pyknosis and cellular 
disintegration (69). These changes are similar to effects of 
TNF on endothelial cells. Finally, through the role of TNF in 
the regulation of protein expression, TNF could encourage 
tissue replacement of the CL and the stimulation of fibroblast 
growth thus changing the highly vascular and functional CL 
into an avascular, nonfunctional corpus albicans which is made 
up of primarily collagen, macrophages and fibroblasts (56). 
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PAPER I 
MACROPHAGE INFILTRATION INTO THE PORCINE CORPUS 
LUTEUM DURING PROSTAGLANDIN F2-ALPHA INDUCED LUTEOLYSIS 
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ABSTRACT 
Although it has been reported that the number of 
macrophages increases in the pig corpus luteum (CL) at the 
time of luteolysis, the temporal association between this 
infiltration and the sequence of events involved in luteolysis 
has not been established. In this study, single CL on an 
ovary of estrogen-treated pseudopregnant gilts were induced to 
undergo luteolysis after the introduction of prostaglandin ¥2^ 
(PGF)-impregnated silastic implants on day 13 (day 0 = first 
day of estrus). Other CL on the same ovary were treated with 
implant material only (vehicle implanted) or left unimplanted. 
At 6, 12, and 24 h after implant placement, CL were removed 
and progesterone concentrations as well as the number and 
location of macrophages within each CL were determined. 
Progesterone concentrations declined significantly (p < 0.05) 
by 12 and 24 h post-implantation in PGF-treated CL but not in 
vehicle implanted or unimplanted CL. There was a significant 
influx (p < 0.05) of macrophages at 6 h in all implanted CL 
(PGF or vehicle implanted) when compared with unimplanted CL. 
In PGF-treated CL, macrophage numbers progressively increased 
through 24 h. In contrast, although a macrophage influx also 
occurred in vehicle implanted CL at 6 h, mac rophage numbers 
progressively declined through 24 h. The simplest explanation 
for these data is that the initial rise in macrophage numbers 
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at 6 h after CL implantation is a result of the implantation 
procedure itself. Further, the observation that most of the 
macrophage influx occurred after the decrease in progesterone 
concentration in PGF-treated CL is consistent with their role 
in phagocytosis of cellular debris. 
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INTRODUCTION 
Prostaglandin F2-alpha (PCF) is the purported luteolysin 
in the pig [1]. However, the exact mechanism(s) involved in 
PGF-induced luteolysis is unclear [2]. One possibility is 
that exposure of the corpus luteum (CL) to PGF results in an 
influx of leukocytes and that these leukocytes play an 
important role in the luteolytic process through their release 
of cytokines and/or their phagocytic properties. Several 
lines of evidence support this hypothesis. First, it has been 
observed that the number of leukocytes increases significantly 
in luteal tissue at the time of luteolysis in the rat, mouse, 
sheep, rabbit, guinea pig, human, cow, and pig [3-13]. 
Macrophages are the primary leukocytes present at the time of 
luteolysis in the pig CL [13] and co-culture of macrophages or 
their products with luteal cells has been shown to modulate 
steroidogenic function of these cells [4, 14, 15]. 
Additionally, a subset of T lymphocytes, T cytotoxic/ 
suppressor lymphocytes (CD8+), possesses cytotoxic activity 
and has been reported to preferentially (compared to T helper 
lymphocytes) infiltrate into the CL of the rat [16]. Products 
of T lymphocytes inhibit both non-stimulated and hCG-
stjLmulated progesterone release by human granulosa/lutein 
cells [17]. 
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The specific objective of the present study was to 
determine the temporal association between functional 
luteolysis (i.e., progesterone decline) and the infiltration 
of macrophages and CD8+ T lymphocytes into the porcine CL. To 
ascertain the temporal association between macrophage and CD8+ 
T lymphocyte infiltration into the CL and progesterone 
production, CL were removed at 6, 12, and 24 h after 
intraluteal implantation of PGF. 
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MATERIALS AND METHODS 
Experimental Model 
Nine Yorkshire gilts (6-8 months old) exhibiting estrous 
cycles of normal duration (19-21 days) were treated i.m. with 
5 mg estradiol benzoate in 2.5 ml of sesame seed oil on Days 
11, 12, and 13 of the estrous cycle (Day 0 = first day of 
estrus). This treatment has been shown to delay luteolysis 
through Day 19 by preventing uterine release of PGF [18]. 
Each gilt was assigned to surgery at 0800 h on Day 13. 
Anaesthesia was induced with Surital (Park-Davis, Morris 
Plains, NJ) and maintained with halothane (Halocarbon 
Laboratories, Inc., Hackensack, NJ) and oxygen [19]. 
Following a midventral laparotomy approach, the reproductive 
tract was exteriorized, and CL were selected to receive 
intraluteal silastic implants according to the method 
described by Ford and Christenson [20]. Briefly, pairs of CL 
on one ovary were marked with different numbers of silk 
ligatures (placed in the ovarian stroma) to allow the 
identification of treatment groups. Pairs were then selected 
to receive intraluteal silastic implants containing either 
lOOMg PGF or no added hormone (termed vehicle, VEH). All 
additional CL on that ovary remained unimplanted (UNI) The 
opposite ovary was removed at the time of implant placement, 
and all CL from this ovary served as the 0 h controls (CTL). 
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This model has been reported [20] to induce a decline in both 
progesterone concentration and luteal weight of PGF-treated 
CL, yet not VEH-treated or UNI CL on the same ovary. 
The silastic compound used to make the implants was 
prepared by mixing 250 /il of Medical Grade Elastomer #382 and 
250 fJLl Medical Fluid #360 (Dow Corning Corporation, Midland, 
MI) with catalyst (stannous octate: Dow Corning Corporation, 
Midland, MI), as previously described [21], in a sterile tube 
with or without 1 mg PGP. Fifty fil of silastic compound with 
or without PGF (100 /xg) was injected through an 18-gauge 
needle into the center of an individual CL, resulting in the 
in-situ formation of a solid intraluteal implant. 
The treated ovary was removed from gilts at 6 (n = 3), 12 
(n = 3) or 24 (n = 3) h post implantation. All CL from each 
animal were individually dissected away from the stroma and 
weighed. Each CL was then cut in 2 equal pieces, and the 
implant (if present) was removed and weighed. Each CL was 
then cut into quarters; one quarter was cut into two pieces, 
one being near the implant (inner) and the other being distant 
to the implant (outer). Inner (center of the CL) and outer 
(periphery of the CL) regions were also collected for UNI and 
CTL samples. All inner and outer pieces were weighed, frozen 
on dry ice, and subsequently used to determine the 
progesterone concentration in luteal tissue. 
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An additional quarter of each CL was placed in a freezing 
dish containing an embedding compound (O.C.T., Miles Inc., 
Elkhart, IN) and specifically orientated so that serial 
sections would contain both inner and outer regions. 
Additional O.C.T. was added, and the tissue was placed in 
liquid nitrogen (snap frozen) . Tissues were stored at -70°C 
and later processed and used in an immunocytochemistry (ICC) 
procedure for the identification of macrophages and CD8+ T 
lymphocytes. 
Progesterone Assay 
Inner and outer pieces of each CL were used to determine 
concentrations of progesterone by using a radioimmunoassay 
(RIA) as described previously [22]. Sensitivity of the assay 
was defined as the amount of steroid that yielded 95% of the 
counts per min in the buffer control tubes; this amount 
averaged 50 pg. Intra- and inter-assay coefficients of 
variation for the assay were 15.8% and 10.7%, respectively. 
Immunocytochemistry 
Stored tissues were removed from the -70°C freezer and 
cut into 8 /im frozen, thin sections, using a cryostat. 
Sections of each CL were placed on slides that had been 
previously treated with Vectabond (Vector Lab., Burlingame, 
CA) to ensure that they would remain attached throughout the 
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immunocytochemistry protocol. Sections were thawed in Tris 
buffer for 5 min at room temperature and then placed in 0.3% 
H2O2 for 1 h to eliminate endogenous peroxidase activity. 
Sections were then washed for 5 min in Tris and placed into 
humidified boxes. Immunocytochemistry was performed using a 
Vectastain ABC kit (Vector Lab) according to the protocol 
provided with the kit. All steps, unless otherwise stated, 
were carried out at room temperature. Tissues were incubated 
with normal goat serum for 20 min. This was followed by an 
overnight incubation with a 1:200 dilution of primary antibody 
in Tris-PBS at 4°C. The primary antibody used to detect 
macrophages was a monoclonal antibody which has been reported 
by the supplier to specifically recognize a surface antigen 
present on porcine monocytes and macrophages (anti-Ml, 
PG130A). The antibody used to detect CD8+ T lymphocytes (also 
called T cytotoxic/suppressor lymphocytes) was a monoclonal 
antibody against the surface antigen CD8 (PT36B). Both 
antibodies were purchased from Veterinary Medical Research and 
Development (VMRD, Pullman, WA). After an overnight 
incubation, sections were washed with Tris for 20 min. The 
biotinylated secondary antibody and avidin biotin complex 
(ABC) incubations were performed for 30 min with a 10 min Tris 
wash in between incubation periods. A :-amino-9-
ethylcarbazole (AEC) horseradish peroxidase kit (Vector Lab) 
was used to visualize positive staining (10 min at 37°C). 
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Sections were then washed in distilled water for 5 min and 
counter-stained with Instant Hematoxylin (Shandon, Pittsburgh, 
PA) for 10 sec. This was followed by a decolorization step in 
ammonia water (1 ml of 17 M ammonia hydroxide, 500 ml tap 
water) for 10 sec. Slides were then washed in tap water for 5 
min and mounted with Aqua-Mount (Lerner Laboratories, 
Pittsburgh, PA). Differences in the average number of 
macrophages and CD8+ T lymphocytes were evaluated as follows. 
Immune Cell Quantification 
Macrophages and CD8+ T lymphocytes were quantified by 
counting 3 randomly selected areas (15.5 x lO'* of inner and 
outer regions of each CL section. For each 15.5 x 10^ area, 
the location and number of macrophages or CD8+ T lymphocytes 
were noted, i.e., the number of cells in vessels (lymphatic, 
arterioles, or venules) and the number of cells in the 
parenchyma. The number of cells counted in the large vessels, 
parenchyma, and the total of these two values were then used for 
statistical analysis. 
Immunocytochemistry Controls 
Controls included omission of primary antibody, secondary 
antibody, or ABC during the ICC procedure. In addition, a 
monoclonal antibody of the same isotype, mouse IgM against a 
plant viral antigen and mouse IgG against a mycobacteria 
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antigen, was used in place of anti-Ml or anti-CD8, respectively. 
No staining was noted in any of these control sections. As a 
positive control, specific staining was shown in sections of 
tissues with known macrophage and CD8+ T lymphocyte populations 
(liver and spleen). Because of the low numbers of CD8+ T 
lymphocytes present in the CL, a positive control (spleen) 
tissue was included in all CD8+ T lymphocyte ICC assays. 
Data Analysis 
Differences in progesterone and the number of macrophages 
and CD8+ T lymphocytes were evaluated at each time point (6, 12, 
and 24 h) by least square analysis of variance (ANOVA) of the 
general linear models procedures of the Statistical Analysis 
System (SAS). Effects included in the model were pig, 
treatment, pig*treatment, replicate (pig*treatment), location, 
and treatment*location. Least square means were compared to 
determine differences between treatments. 
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RESULTS 
Macrophage Infiltration Due to Surgery 
Macrophage numbers in UNI CL at 6, 12, and 24 h post 
surgery did not differ from the number of macrophages in 0 h CTL 
CL (Fig. lA) . Moreover, progesterone concentrations did not 
change in UNI CL over time and were similar to those in 0 h CTL 
CL (48 ng/mg CL wet weight; Fig. IB). 
Macrophage Infiltration Due to Implantation of CL 
VEH-treated CL exhibited an initial rise in macrophage 
numbers relative to UNI and PGF-treated CL (p < 0.05; Fig. lA). 
Although macrophage numbers declined progressively in VEH-
treated CL and by 24 h were significantly lower than PGF-treated 
CL, macrophage numbers for VEH-treated CL remained significantly 
higher than those for UNI CL (p < 0.05) at all time points. 
However, progesterone concentrations did not change over time in 
VEH-treated CL and were similar to concentrations in both UNI 
and CTL CL (Fig. IB) 
While a few (0-2/field) macrophages were seen in 
the inner portions of CTL and UNI CL, all CL that received an 
implant, regardless of treatment or time, exhibited higher 
numbers of macrophages a. ijacent to the implant than in the 
outer regions (p < 0.001; Table 1). This observation was 
noted when examining the number of macrophages in vessels. 
FIG. 1. Changes in the total macrophage number (A) and the 
concentration of progesterone (B) in ng/mg CL tissue for UNI, 
VEH, and PGF-treated CL at each time period expressed as the 
percent and SEM percent of the 0 h (CTL) CL. Each time period 
is represented by 3 animals and 2 CL/animal for each treatment 
were examined. **Greater than other two treatments at a 
single time point (p < 0.05). *Greater than UNI at a single 
time point (p < 0.05). 
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parenchyma or the total of these two values. Within a single 
CL, however, there were no differences in progesterone 
concentrations of inner and outer pieces for CTL, UNI, VEH- or 
PGF-treated CL at any time point. 
Table 1. Differences between macrophage numbers due to 
location. 
Means of total macrophages 
6 h^ 12 h 24 h= 
Location* PGF VEH PGF VEH PGF VEH 
Inner 59 114 97 68 97 54 
Outer 2 6 11 5 30 6 
^Differences between location (inner>outer) for both PGF- and 
VEH-treated CL, p < 0.001 for 6, 12 and 24 h. 
^Difference between PGF- and VEH-treated CL inner regions at 
6 h p < 0.05. 
^Difference between PGF- and VEH-treated inner regions at 24 h 
p < 0.05. 
Macrophage Infiltration Due to PGF Implantation into a CL 
Macrophage numbers in PGF-treated CL were elevated at 6 h 
(compared with UNI, p < 0.05) and progressively increased to 
reach significantly greater numbers at 12 and 24 h (p < 0.05; 
Fig. lA). Furthermore, by 24 h post implantation, macrophage 
numbers were significantly higher in PGF-treated CL when 
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compared with VEH-treated CL (p < 0.01). This difference 
resulted from the greater number of macrophages in the inner 
region of PGF-treated CL (Table 1). Progesterone 
concentration in PGF-treated CL had declined significantly 
(p < 0.05) by 12 and 24 h post PGF-implantation (Fig. IB) 
Macrophage Infiltration into Vessels 
There were no differences in the number of macrophages in 
large vessels (blood or lymphatic) between UNI, VEH- and PGF-
treated CL at 6 and 12 h. However, by 24 h post implantation, 
a greater number of macrophages were present in the large 
vessels for both VEH- and PGF-treated CL when compared with 
UNI CL (Fig 2, p < 0.01). 
Macrophage Infiltration into the Parenchyma 
At 6 h post implantation, there were more macrophages in 
the parenchyma of VEH-treated CL than in PGF-treated CL or UNI 
CL (p < 0.05). When compared with PGF-treated CL, the 
increase in parenchymal macrophages in VEH-treated CL at 6 h 
was exclusively an effect of the influx of macrophages 
adjacent to the implant (p < 0.05) because the number of 
macrophages in the outer region did not differ between these 
two treatments (Table 1). At 12 and 24 h post implantation, 
the number of macrophages was greater in the parenchyma of 
PGF- and VEH-treated CL (p < 0.05) than in that of UNI CL 
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(Fig. 3)• Although there were no differences in macrophage 
numbers between PGF- and VEH-treated CL at 12 h, significantly 
more macrophages were present in the parenchyma of PGF-treated 
CL when compared with VEH-treated CL by 24 h (p < 0.05). 
Again the difference was attributable to an increase in the 
number of macrophages adjacent to the implant (p < 0.05; Table 
1) . 
CD8+ T Lymphocyte Infiltration 
CD8+ T lymphocytes were rarely seen (0-1 per 15.5 x lO^^m^ 
field) in the CL. When analyzed by ANOVA, no differences were 
noted among treatments, times or location of CD8+ T 
lymphocytes in CL. 
FIG. 2. Immunocytochemistry of a CL section 12 h post PGF 
implantation. Marked infiltration of macrophages from large 
vessels were especially prominent in PGF-treated CL. An ICC 
protocol was used to visualize porcine macrophages using a 
monoclonal antibody against a surface antigen on this cell 
type. The chromogen used was AEC. The result is a red 
staining pattern around the periphery of the macrophages 
(80.5X). Instant Hematoxylin was used to counterstain 
sections. 
FIG. 3. Immunocytochemistry of a CL section 24 h post PGF 
implantation. Infiltration of macrophages was noted in 
parenchyma of PGF-treated CL often specifically associated 
with luteal cells (63.4X). 
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DISCUSSION 
The temporal relationship between functional luteolysis 
(as measured by a decline in progesterone concentration in the 
CL) and the infiltration of macrophages and CD8+ T lymphocytes 
into CL during PGF-induced luteolysis was examined. An 
increase in macrophage numbers was seen before a decline in 
progesterone content of PGF-treated CL. This observation is 
consistent with the premise that macrophages may play a role 
in the early stages of PGF-induced luteolysis in this species. 
However, further evaluation of these data suggests this 
initial macrophage influx may be associated with the 
implantation procedure itself. This idea is supported by the 
observation that a significant macrophage influx into VEH-
treated CL was noted at 6 h, and macrophage numbers at this 
time were higher than those noted in PGF-treated CL. 
Additionally, although macrophage numbers in VEH-treated CL 
remained significantly higher than in UNI CL for all time 
periods, no alteration in subsequent progesterone secretion by 
VEH-treated CL was noted at 6, 12, and 24 h post implantation. 
Thus, an influx of a large number of macrophages does not seem 
to result in functional luteolysis in the pig. This is the 
first experiment to directly examine the effect of an induced 
macrophage infiltration into the CL, and it is consistent with 
the results of a recent study of the rabbit by Seiner et al. 
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[23]. These authors provided evidence that the influx of 
macrophages and T lymphocytes into the CL is not essential for 
luteolysis to occur in that species. 
The elevated macrophage numbers in VEH-treated CL may have 
resulted from an implantation-induced inflammation and 
hyperemia. A possible explanation for the "delay" of a 
macrophage influx into PGF-treated CL at 6 h compared with 
VEH-treated CL is that PCF, a potent vasoconstrictor, could 
have decreased CL blood flow and subsequent infiltration of 
macrophages into PGF-treated CL by 6 h. Prostaglandin ¥2^ has 
been shown to reduce blood flow to the CL within 4 h of in 
vivo administration in the sheep [24]. 
The progressive increase in macrophage numbers over time 
noted in PGF-treated CL but not in VEH-treated CL suggests 
that PGF may be acting to attract macrophages into CL during 
the luteolytic process. In support of a chemotactic activity 
of PGF, research by Murdoch and McCormick [25] has shown that 
treatment with indomethacin, a PGF synthesis inhibitor, 
results in a significant decrease in leukocyte migration into 
follicles. That a chemotactic signal occurred as a result of 
exposure of luteal tissue to PGF in the present study is 
supported by three observations. First, macrophages were not 
present in large numbers in UNI and CTL CL. Second, a number 
of macrophages were apparent in many large vessels (lymphatic 
or blood) of PGF-treated CL, and macrophages appeared 
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"attached" to the endothelial cells lining the vessels in CL 
treated with PGF. Third, a number of macrophages were often 
present in the parenchyma of PGF-treated CL near vessels. 
These observations suggest that the majority of macrophages 
detected resulted from a recent infiltration of this cell type 
into the CL in response to PGF. From these data, however, we 
cannot determine if PGF is acting in a direct or an indirect 
manner [i.e., through stimulation of known chemotactic 
factor(s)] to attract macrophages into the CL of the pig. 
In the rabbit [6], a macrophage infiltration into the CL 
follows the invasion of T lymphocytes in this tissue. 
Additionally, CD8+ T lymphocytes seem to be selectively 
recruited into the rat CL at regression [16]. However, in the 
present study, a CD8+ T lymphocyte infiltration was not noted. 
While these data do not agree with results obtained in rabbits 
and rats [6,16], they are in agreement with a study of CD8+ T 
lymphocytes in the human CL [10]. Because very few CD8+ T 
lymphocytes were evident at luteolysis in the present study, 
it is unlikely that T cytotoxic/suppressor lymphocytes are 
involved in this process in the pig. 
In summary, we present compelling evidence to suggest that 
the primary function of macrophages in the luteolytic process 
in the pig is unlikely to be the initiation of functional 
luteolysis. This statement is supported by the observation 
that a significant influx of macrophages into CL that had not 
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been exposed to PGF did not result in functional luteolysis. 
However, both functional and structural regression are 
important in luteolysis. It is possible that the exposure of 
luteal cells to macrophages may be necessary for the 
completion of the luteolytic process in this species through 
the phagocytosis and removal of luteal cells after they have 
undergone luteolysis (structural regression). 
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ABSTRACT 
The objectives of this study were to verify the presence 
of tumor necrosis factor (TNF) in pig corpora lutea (CL), to 
determine whether the reproductive state of the animals 
influenced the presence of TNF in the CL, and to determine 
which cells of the CL were associated with TNF. Western blot 
analysis demonstrated the presence of 17 and 34 kDa 
immunoreactive TNF proteins in CL from cyclic and pregnant 
pigs. The intensity of TNF immunostaining as detected by 
western blot analysis did not differ between CL collected from 
cyclic and pregnant pigs or from CL collected from pigs during 
early, mid and late pregnancy. Positive immunostaining for 
TNF, as determined by immunocytochemistry, was present in CL 
at all reproductive states examined. Immunocytochemical 
analysis confirmed TNF to be associated with endothelial cells 
of steroidogenically active CL. Moreover, a reverse hemolytic 
plaque assay determined that TNF secreting cells exist in the 
pig CL. The presence of TNF in steroidogenically active, 
highly vascularized CL, together with its cellular 
localization to endothelial cells is consistent with a role 
for TNF in the regulation of vascular development of the CL in 
pigs. 
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INTRODUCTION 
Tumor necrosis factor (TNF) has a wide range of biological 
activities including cell cytotoxicity or damage, cell 
protection (to oxidative injuries), cell differentiation and 
tissue development (1). Tumor necrosis factor has been 
detected in the corpus luteum (CL) of the rabbit (2), human 
(3) rat, and cow (4), however, its relationship to the 
reproductive state of these females has not been established. 
Moreover, the source of TNF within the CL has not been 
conclusively determined. Roby et al. (3), reported TNF to be 
present in large luteal cells and paraluteal cells of the 
human CL. In contrast, other studies suggest that macrophages 
are the source of TNF in the CL (2,4). 
The presence of TNF within the CL is consistent with a 
role for this cytokine in luteal function. One potential role 
for TNF in the CL may be in the regulation of luteal cell 
steroidogenesis (5). In support of this hypothesis, TNF has 
been shown to alter steroidogenesis by granulosa cells (3,6-9) 
the purported precursor of large luteal cells (10). Another 
possible role for TNF in the CL is the regulation of the 
proliferation of cells within the CL. Tumor necrosis factor 
has been shown to enhance endothelial cell growth in vivo (11) 
and endothelial cells compose up to 50% of the mature CL (12). 
Furthermore, TNF induces the production of cytokines such as 
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interleukin-1 and interleukin-6 (13) by endothelial cells and, 
as the majority of large luteal and small luteal 
(steroidogenic) cells are adjacent to one or more capillaries 
(14,15), cytokines produced by TNF-stimulated endothelial 
cells may have growth regulatory activities on luteal cells. 
In the present study, CL from cyclic and pregnant pigs 
were analyzed by western blot analysis to determine the 
presence and potential changes of TNF in CL throughout the 
estrous cycle and pregnancy. In addition, CL from cyclic and 
pregnant pigs were examined by immunocytochemistry (ICC) in 
order to establish the cellular localization of TNF. Finally, 
a reverse hemolytic plaque assay (RHPA), which measures 
secretion of TNF at the single cell level, was used to examine 
dispersed CL in order to establish the presence of TNF 
secreting cells in the pig CL. 
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MATERIALS AND METHODS 
Corpora lutea were collected from nonpregnant pigs 
immediately before, during, and after the time of normal 
luteolysis (days 12-16, day 0 = first day of estrus) and 
initially examined for both TNF and macrophages by ICC. 
Macrophages have been reported to infiltrate into pig CL 
during luteolysis (16) and evidence exists for production of 
TNF by macrophages within the CL (2). As TNF did not appear 
to be associated with CL macrophages, additional CL collected 
from pregnant pigs along with day 12-16 CL from cyclic animals 
were subsequently examined for TNF by western blot analysis 
and a RHPA. Moreover 8 /nm frozen sections of these CL were 
examined for TNF and endothelial cells by ICC as endothelial 
cells are a primary target for TNF (1). 
Collection of CL from Cyclic Pigs 
Ovariectomy was performed on days 12 (n=2), 13 (n=l), 14 
(n=2), 15 (n=3) and 16 (n=l) of an estrous cycle in Yorkshire 
gilts. Anaesthesia was induced with Surital (Park-Davis, 
Morris Plains, NJ) and maintained with halothane (Halocarbon 
Laboratories, Inc., Hackensack, NJ) and oxygen (17). 
Following midventral laparotomy, the reproductive tract was 
exteriorized, and the ovaries were removed. Three CL/animal 
were dissected away from the ovarian stroma and weighed. Each 
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CL was then cut into two equal pieces. One piece was weighed, 
placed on dry ice and frozen at -90°C until evaluated for 
progesterone (as a measure of functional luteolysis) using a 
fully validated radioimmunoassay (RIA; 18). The other piece 
was placed in a freezing dish containing an embedding compound 
(O.C.T., Miles Inc., Elkhart, IN) and snap frozen in liquid 
nitrogen. This piece was stored at -70°C until processed for 
ICC. Additional CL were processed for use in western blot 
analysis and RHPA. 
Collection of CL from Pregnant Pigs 
Ovaries from pregnant pigs of various gestational ages 
were collected at the time of slaughter at the Iowa State 
University Meat Laboratory. Early (day 8-15; n=3), mid (day 
45-60; n=2) and late (day 80-112; n=3) gestational stages were 
represented in this study. Gestational ages were determined 
either by the known date of first mating (day 0) with an 
intact boar (early group) or by crown-rump length of the fetus 
(mid and late groups; 19). The ovaries were handled and CL 
processed as previously described for cyclic pigs. 
Western Blot Analysis 
Three '_o four CL were dissected away from the ovarian 
stroma, weighed, homogenized in PBS, pelleted at a slow speed, 
and the supernatant centrifuged at 21,000 rpm for 90 min at 
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4°C. The resulting supernatants were aliquoted and frozen at 
-70°C until used in western blot analysis. 
Each CL homogenate was assayed for total protein using a 
Bio-Rad Protein Assay Kit (Bio-Rad Labs, Richmond, CA), 
following the company instructions. One-hundred twenty eight 
jug of protein/lane were separated for western blot analysis 
using a BioRad Mini-Protean II Cell (Bio-Rad Labs). 
Electrophoresis and protein blotting were performed according 
to directions provided by Bio-Rad Labs with minor 
modifications. Briefly, CL samples were mixed 4:1 with sample 
buffer [62.5 mM tris-HCL, 10% glycerol (v/v), 2% SDS (v/v), 
0.05% 2-mercaptoethanol (v/v), 0.0125% bromophenol blue (v/v), 
in deionized water] and solubilized for 3 min at 85-90°C prior 
to loading onto a 16% Tris/glycine pre-cast gel. Molecular 
weight (MW) markers, 14.3-66 kDa, were run concurrently with 
the CL samples and all proteins were separated at 31 mA for 
30-35 min. After separation of the proteins, the gel, 
Scothbrite pads, blotting filters and a 0.2 /xm nitrocellulose 
membrane were soaked in transfer buffer [96 mM glycine, 20% 
methanol (v/v), and 12 mM Tris-HCL] for 30 min, prior to 
protein transfer. The separated proteins were transferred 
from the gel to the nitrocellulose membrane in ice cold 
transfer buffer at 200 mA for 1 h. f allowing transfer of the 
proteins to the nitrocellulose membrane, the bound proteins 
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were visualized with Ponceau S for 5 min and the location of 
the MW markers were permanently recorded on the membrane. 
The nitrocellulose membrane containing the blotted 
proteins was incubated overnight with rabbit anti-human tumor 
necrosis factor-a antiserum (Genzyme, Cambridge, MA) which was 
diluted 1:200 in buffer solution after blocking for non­
specific sites with 2% powered milk. Determination of 
immunoreactive TNF in separated protein bands was achieved 
using a Vectastain ABC Kit (Vector Lab. , Burlingame, CA) 
following company instructions. Immunoreactive TNF was 
visualized using a 0.025% solution of 3•,3•-diaminobenzidine 
in Tris containing 0.03% H2O2 (DAB). 
Quantification of TNF Detected by Western Blot Analysis 
The intensity of immunoreactive TNF on western blots was 
analyzed with a Zeiss SEM-IPS analysis system (Zeiss-Kontron 
version 2.00). Each blot was placed on a copy stand and 
viewed with a Kodak XC-77 black and white video camera. The 
mean gray value of a line through the center of the 17 and 34 
kDa immunoreactive TNF bands for each CL sample was then 
measured. A sample from a Day 8 pregnant CL was included in 
each western blot analysis in order to standardize intensity 
measurements from gel to gel. The sum of the intensity values 
for the 17 and 34 kDa immunoreactive TNF bands from the Day 8 
CL was calculated and assigned a value of 100. The sum of the 
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values for the 17 and 34 kDa immunoreactive TNF bands for all 
other CL were calculated and expressed as a percent of the Day 
8 CL value. 
The control procedures for western blot analysis included 
the substitution of the primary antibody with normal rabbit 
serum or omission of the primary antibody, secondary antibody, 
or the avidin-biotin complex (ABC). All of these controls 
abolished immunoreactive TNF staining of the membrane-bound 
proteins. Additionally, the primary antibody (TNFa antisera, 
10 nl) was preabsorbed for 2 h at room temperature with 10,000 
U of recombinant human TNFa prior to its use in western blot 
analysis. This human recombinant TNFa was reported by the 
supplier (Genzyme) to specifically bind to the primary 
antibody. 
Reverse Hemolytic Plaque Assay 
Three to four CL each were collected from day 14 and 15 
non-pregnant gilts and from day 9, 10, 12 and 37 pregnant 
gilts. Luteal tissue obtained from a single animal was then 
dispersed using a previously described method (20). This cell 
dispersate was then used in a TNF-RHPA which has been 
described previously (20,21). Briefly, incubation chambers 
were constructed by attaching a cover-slip to a poly-L-lysine-
treated glass microscope slide using double stick tape. 
Luteal cells (0.25 X 10® large luteal cells/ml) were mixed 1:1 
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with a 12% suspension of ovine red blood cells to which 
protein-A (Sigma, St. Louis, MO) had been attached by the 
chromium chloride conjugation method (22), and infused into 
incubation chambers by capillary action. After a 45-min 
incubation (this and all other incubations were carried out in 
a 5% C02-95% air humidified atmosphere), the chambers were 
flushed with Dulbecco's Modified Medium (Gibco, Grand Island 
NY)-0.1% BSA (Sigma; DMEM+) to remove unattached cells. 
Monolayers were then filled with a rabbit anti-human TNFa 
polyclonal antibody (Genzyme) diluted 1:40 in DMEM+ and 
incubated for 8 h. After the incubation period, chambers were 
filled with guinea pig serum as a source of complement (1:40, 
Gibco), incubated for 50 min to allow plaque formation, and 
then the monolayers were fixed in 1.8% glutaraldehyde in 
normal saline. Monolayers were viewed microscopically to 
determine plaque formation. 
As controls for this RHPA the TNFa antibody or complement 
was eliminated from the RHPA protocol. Additionally the 
primary antibody (rabbit anti-human TNFa) was substituted with 
preimmune rabbit serum in the RHPA protocol. No plaques were 
noted in any of these controls. 
Immunocytochemistry 
Stored tissues were removed from the -70°C freezer and cut 
into 8 fj,m frozen sections using a cryostat. Sections were 
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thawed in Tris and placed in 0.3% HgOg for 1 h to eliminate 
endogenous peroxidase activity. Sections were then washed in 
Tris and placed into humidified boxes. Immunocytochemistry 
for TNF, macrophages or endothelial cells was performed using 
a Vectastain ABC kit (Vector Lab) following company 
instructions. 
ICC protocol for TNF. Sections for detecting TNF were 
incubated for 4 h at room temperature with a rabbit anti-human 
TNFa polyclonal antibody (1:800 dilution in Tris-PBS, 
Genzyme). The chromogen used to visualize TNF was DAB and 
sections were counter-stained with Instant Hematoxylin 
(Shandon, Pittsburgh, PA). 
Controls for detecting TNF in CL sections by ICC consisted 
of elimination of the primary antibody, secondary antibody or 
ABC during the ICC protocol. No staining was noted in the 
elimination control sections. Additionally, substitution of 
the primary antibody with a similar protein concentration of 
normal rabbit serum, eliminated specific staining for TNF. 
Moreover, a significant decline in staining for TNF occurred 
when the primary antibody was preabsorbed with 500 U of 
recombinant TNF (Genzyme) for 2 h at room temperature prior to 
incubating with tissue sections. 
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ICC protocol for macrophages. Sections of CL for 
detecting macrophages were incubated overnight at 4°C with a 
monoclonal antibody (1:200 dilution in Tris-PBS) which has 
been reported by the supplier to specifically recognize a 
surface antigen present on pig monocytes and macrophages 
(anti-Ml, PG130A; Veterinary Medical Research and Development, 
Pullman, WA). A 3-amino-9-ethylcarbazole (AEG) horseradish 
peroxidase kit (Vector Lab) was used to visualize positive 
staining for macrophages and slides were counter stained with 
Instant Hematoxylin (Shandon). 
Controls for macrophage staining included omission of 
primary antibody, secondary antibody, or ABC during the ICC 
procedure. In addition, a monoclonal antibody of the same 
isotype, mouse IgM against a plant viral antigen, was used in 
place of the primary antibody. No staining was noted in any 
of these control sections. As a positive control, specific 
staining was shown in sections of tissues with known 
macrophage populations (liver and spleen). 
ICC protocol for endothelial cells. Sections of CL 
were incubated for 1 h at room temperature with a 1:500 
dilution (in Tris-PBS) of antibody against von Willebrand's 
Factor (vWF; Dako, Carpinteria, CA). von Willebrand's Factor 
is produced by endothelial cells and megakaryocytes, and 
antibody against this protein specifically binds to 
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endothelial cells, megakaryocytes or platelets (23). The 
protocol for visualization of vWF was identical to the 
macrophage protocol. 
Controls for vWF staining included omission of primary 
antibody, secondary antibody, or ABC during the ICC procedure. 
No staining was noted in any control sections. 
Progesterone Assay 
Portions of CL collected from gilts on days 12-16 of the 
estrous cycle were used to determine concentrations of 
progesterone using a radioimmunoassay (RIA) as described 
previously (18). Sensitivity of the assay was defined as the 
amount of steroid that yielded 95% of the counts per min in 
the buffer control tubes, which averaged 50 pg. Intra and 
inter-assay coefficients of variation for a luteal tissue pool 
were 11.3% and 35.8%, respectively. 
Quantification of Macrophages 
Macrophages were quantified by counting 3 randomly 
selected areas (15.5 x lO'* of each CL section. For each 
15.5 X lo'^ area, the location of macrophages i.e., th 
presence of macrophages in vessels (lymphatic, arterioles, or 
venules) or the parenchyma was noted. 
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Data Analysis 
One-way ANOVA (24) was used to analyze the differences in 
the intensity of immunoreactive TNF bands identified by 
western blot analysis between the early, mid, and late 
pregnant CL and non-pregnant CL (days 12-16) groups. 
Corpora lutea were divided into 2 groups, 
steroidogenically inactive (less than 20 ng progesterone/mg CL 
wet weight) and steroidogenically active (greater than 20 ng 
progesterone/mg CL wet weight) and the difference in 
macrophage number in these two groups of CL was analyzed by 
one-way ANOVA (24). Groupings of CL were based on 2 studies 
(25,26) which showed the progesterone concentrations of 
steroidogenically inactive CL to average 15 ng/mg with a range 
of 8-18.3 ng/mg. 
100 
RESULTS 
Western Blot Analysis of TNF in CL 
The TNF antibody specifically bound to proteins with 
molecular weight of 17 and 34 kDa (Fig. 1). Specific TNF 
staining to these proteins was not observed when the 
preabsorbed antibody was used to detect the presence of TNF in 
membrane-bound proteins. Moreover, tumor necrosis factor-a 
antibody bound to recombinant human TNFa (Genzyme) with a 
molecular weight of 17 and 34 kDa (Fig. 1). These bands were 
equivalent to a monomer and dimer of TNF, respectively. Tumor 
necrosis factor was detected in CL from pigs during the 
estrous cycle (day 12 and 15) and pregnancy (early, mid and 
late) with no differences in staining intensities. 
Reverse Hemolytic Plaque Assay for TNF Releasing Cells in the 
CL 
All luteal samples examined for TNF releasing cells by 
RHPA possessed cells which formed plaques (Fig. 2). The size 
of the TNF secreting cells appeared to be slightly larger than 
ovine red blood cells, a size similar to an leukocyte or 
endothelial cell. 
Figure 1: Western blot analysis of luteal tissue from cyclic 
and pregnant pigs. Lanes marked with asterisk are luteal 
tissue from non-pregnant pigs. Purified recombinant human TNF 
was included in the lane on the far right. Tumor necrosis 
factor antisera bound to separated proteins equivalent to 17 
and 34 kDa. 
Figure 2: A representative plaque formed by a TNF releasing 
cell from a day 14 non-pregnant pig (30X). Tumor necrosis 
factor releasing (plaque forming) cells as measured by a 
reverse hemolytic plaque assay were present in all stages of 
CL examined. 
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Localization of TNF, Macrophages and Endothelial Cells in CL 
by ICC 
Tumor necrosis factor was detected by ICC in all CL 
samples examined. Tumor necrosis factor was commonly 
associated with clusters of cells found distributed throughout 
each CL section which were darkly stained with hematoxylin 
(Fig. 3). Tumor necrosis factor was also evident in the walls 
of capillaries or other vessels within the CL. 
Macrophages were rarely seen (0-3/field) in 
steroidogenically active CL (greater than 20 ng progesterone/ 
mg CL wet weight). When macrophages were noted in 
steroidogenically active CL, they were most often within blood 
or lymphatic vessels, especially in the capsular region 
surrounding the CL. As CL progesterone concentrations 
declined, macrophages -appeared to migrate from peripheral 
vessels into the parenchyma of the CL. 
Endothelial cells, as detected by positive vWF staining, 
were abundant in all CL examined. Endothelial cells often 
appeared in clusters of cells located in discrete areas 
throughout the CL (Fig. 4). Staining for vWF occurred in 
similar locations as TNF staining in sections of the same CL 
(Fig. 3 and 4). 
Figure 3: Iramunocytochemistry staining for TNF in a 8 
frozen section of a day 15 non-pregnant pig CL (128.6X). The 
chromogen used to visualize TNF was DAB which appears brown. 
Sections were counter-stained with hematoxylin. 
Figure 4: Immunocytochemistry staining for endothelial cells 
(as detected by vWF) within the same CL as Figure 3 (128.6X). 
The chromogen AEC which appears red was used to visualize vWF. 
Sections were counter-stained with hematoxylin. 
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Macrophage Infiltration and Correlation with Progesterone 
Concentration of CL 
Macrophage numbers in the CL remained low (0-3 macrophages/ 
field) throughout gestation. There were significantly more 
(p<0.01) macrophages in steroidogenically inactive CL (x = 
12.22/15.5 X 10^ compared to steroidogenically active CL (x 
= 2.2/15.5 X lO'* nm^) . 
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DISCUSSION 
This is the first study to show the presence of TNF in pig 
CL and to relate the presence of TNF to the reproductive 
status of the female. Monomeric and dimeric forms of TNF were 
detected by western blot analysis. Multimer forms of TNF 
found by western blot analysis are consistent with the 
observation that multiple forms of TNF exist (27). 
Positive immunostaining for TNF as determined by both 
western blot analysis and ICC, occurred in CL of all 
reproductive states. There were no obvious differences in the 
degree of TNF immunostaining as detected by western blot 
analysis between reproductive states of the female. As the 
intensity of TNF immunostaining did not change in CL 
throughout the estrous cycle, it is unlikely that TNF has a 
role as a luteolytic substance or regulator of steroidogenesis 
in the pig CL. In support of this observation, Tekpetcy et 
al., (28) reported that TNF does not affect LH-stimulated 
progesterone accumulation by fractions of small luteal cells 
or large luteal cells collected from pigs during days 10-14 of 
the estrous cycle. 
Tumor necrosis factor may act as a growth factor for cell 
populations of the pig CL. For example, fibroblasts, a 
population that makes up approximately 11% of the volume of 
the mature CL (15), respond to TNF with an increase in growth 
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(1). Moreover, TNF stimulates the proliferation of ovarian 
epithelial cells (29). The importance of TNF in the 
regulation of ovarian cell growth is emphasized by the 
observation that abnormal expression and production of TNF in 
the ovary is associated with ovarian carcinomas in humans 
(30) . 
Another possible activity of TNF in the pig CL is the 
regulation of vascular development (31,32) as TNF appeared to 
be associated with the endothelial cells (vWF+). Tumor 
necrosis factor has been reported to induce marked 
morphological changes in endothelial cell shape and to inhibit 
endothelial cell proliferation (1) potentially by a reduction 
of receptors of fibroblast growth factors, a known CL 
angiogenic factor (36,37). Frater-Shroder et al. (11) 
reported that, while TNF inhibited endothelial cell growth in 
vitro, it stimulated growth of endothelial cells in vivo. 
Angiogenic activity is prevalent in the CL of several species 
(12, 33, 34) including the pig (35). Furthermore, both sheep 
and cow CL possess activity which enhances endothelial cell 
growth throughout the estrous cycle and pregnancy (31,38,39). 
Tumor necrosis factor was observed in pig CL throughout the 
estrous cycle and pregnancy in the present study and 
therefore, may be acting as an angiogenic factor in the pig 
CL. 
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Tumor necrosis factor was found to be localized to 
endothelial cells by ICC. Moreover, cells from the pig CL 
which release TNF were detected by RHPA and the size of these 
cells were consistent with an leukocyte or endothelial cell. 
Endothelial cells may be the source of TNF in the pig CL (40). 
It is unlikely, however, that macrophages are a primary source 
of TNF in the pig CL as macrophages were often absent in 
tissues that stained strongly for TNF and TNF was rare in 
tissues with abundant macrophages (day 16). 
In conclusion, this is the first report to show TNF is 
present in luteal tissue from pigs and to examine its presence 
throughout the estrous cycle and pregnancy. Tumor necrosis 
factor was present as a 17 and 34 kDa protein in pig CL. 
There were no differences in the intensity of TNF 
immunostaining, as detected by western blot analysis, during 
the estrous cycle and pregnancy. The presence of TNF in 
steroidogenically active CL and its primary association with 
endothelial cells of the pig CL, is consistent with a role for 
TNF in the regulation of the vascular development of the pig 
CL . 
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GENERAL SUMMARY AND DISCUSSION 
The research presented in this dissertation attempted to 
clarify the role for the immune system in luteal function with 
emphasis on luteolysis in the pig. While several studies have 
examined the effects of soluble leukocyte products (cytokines) 
on luteal cell function in vitro (as reviewed by 48) very few 
studies have established the presence of sufficient numbers of 
leukocytes in luteal tissue to account for the concentration 
of cytokines used in most of these studies. Furthermore, 
while it has been suggested that leukocytes may be important 
in the initiation of luteolysis, the presence of leukocytes 
prior to the initiation of luteolysis in the pig has not been 
established. The study described in Paper I of this 
dissertation, therefore, examined the temporal relationship 
between macrophage infiltration and the functional demise of 
CL of pigs. Because the time of luteolysis can vary from 
animal to animal and from one estrous cycle to the next within 
the same animal, it was necessary to use an experimental model 
to induce luteolysis within a specific time period. The 
experimental model used to study the temporal relationship 
between macrophage infiltration and functional demise of the 
CL, therefore, consisted of the use of intra-luteal silastic 
PGF implants to induce the regression of individual CL. Three 
different controls were included in this model in order to 
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differentiate between the effect of surgery, implantation, or 
PGF treatment. Corpora lutea were removed at 6, 12 and 24 
hours after PGF treatment and the number of macrophages in 
tissue sections was determined using ICC. Moreover, the 
progesterone concentration of each CL was determined as the 
decline in progesterone concentration in luteal tissue is an 
indication of functional luteolysis. Thus, the observation 
that macrophages infiltrate into the CL prior to the decline 
of progesterone in the CL, would provide strong evidence that 
macrophages are important in initial stages of luteolysis. In 
contrast, the observation that macrophages infiltrate into the 
CL after the decline in progesterone concentration of luteal 
tissue, would suggest that macrophages do not play a role in 
initiation of functional luteolysis. As presented in Paper 
I, the large majority of the macrophage infiltration 
associated with luteolysis occurred after the decline of 
progesterone concentrations of the CL suggesting that 
macrophages do not play a role in functional luteolysis in the 
pig. Furthermore, functional luteolysis did not occur in CL 
which were not treated with PGF (vehicle) while a dramatic 
influx of macrophages did occur in the vehicle-treated CL. 
This observation provided further evidence that an 
infiltration of macrophages into luteal tissue does not cause 
luteolysis. Admittedly, the population of macrophages that 
infiltrated into the CL as a result of implantation may not 
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have been "activated" in such a manner that is important in 
luteolysis. This is unlikely, however, as adherence of 
macrophages to endothelial cells and response to a chemotactic 
signal has been shown to activate macrophages (23,30). 
It does not appear that other leukocytes such as 
neutrophils, eosinophils or T lymphocytes play a role in 
functional luteolysis of the pig. While the examination of 
neutrophils and eosinophils in the CL at the time of 
luteolysis was not the focus of the study presented in Paper 
I, both of these cell types have distinct morphology and can 
be identified easily. Neither neutrophils or eosinophils were 
abundant in CL examined. Furthermore, the presence of CD8+ T 
cells in CL during PGF-induced luteolysis was examined and 
these cells were rarely seen in the CL. Therefore, it is 
unlikely that leukocytes are necessary for functional 
luteolysis in the pig. 
The data from Paper I (i.e. PGF-induced luteolysis via 
silastic implants) is consistent with what is seen during 
naturally occurring luteolysis. Part of the data presented in 
Paper II, includes the determination of the number of 
macrophages in CL from days 12-16 of the estrous cycle, a time 
just prior to, during and after the initial stages of 
luteolysis in the pig. Progesterone concentrations of these 
CL were also determined to provide an indication of functional 
luteolysis. Macrophage numbers averaged 2 cells/area (maximum 
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of 8 cells/area) when progesterone concentration in luteal 
tissue indicated that CL were steroidogenically active. Yet, 
when CL progesterone concentrations were less than 20 ng/mg of 
luteal tissue, suggesting functional luteolysis had occurred 
in these CL, macrophage numbers averaged 12 cells/area (area = 
15.5 X lO'^ with a maximum of 38 cells/area. Macrophage 
infiltration in normal tissue appear to occur after functional 
luteolysis has occurred. 
In contrast, macrophages appear to be important in 
structural luteolysis of the CL which is consistent with the 
role of macrophages in wound healing (72). The most dramatic 
infiltration of macrophages into the CL occurred at a time 
when the weight of the CL decreases (20). Moreover, at the 
time of luteolysis, luteal cells are replaced by fibroblasts 
and connective tissue and macrophages stimulate the growth of 
fibroblast (13). The role of macrophages in the CL of pigs, 
therefore, is likely structural luteolysis and not functional 
luteolysis. 
The original hypothesis of this dissertation research was 
that macrophages and products of these cells (such as TNF) 
provide a signal for luteolysis to begin. Tumor necrosis 
factor is a primary product of macrophages and has been 
identified in the CL of the human, rat, rabbit and cow 
(4,64,65). Moreover, several studies suggest that TNF in the 
CL is important in the regulation of steroidogenesis by luteal 
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cells (82,99) or as a cytotoxic factor for luteal cells 
(luteolysis) (48) . The objectives of the study presented in 
Paper II were to determine the presence of TNF in the pig CL, 
to determine whether the reproductive state of animals 
influenced the presence of TNF in CL, and to determine which 
cells of the CL were associated with TNF. Positive 
immunostaining for TNF, as determined by western blot analysis 
and ICC, was present in CL at all reproductive states 
examined. Moreover, there were no differences between the 
intensity of immunostaining present in tissue examined during 
the luteal phase of the estrous cycle and CL throughout 
pregnancy. This observation suggests that TNF in the CL of 
pigs does not act as a luteolytic substance and instead may be 
important in the normal "house keeping" of the CL. One 
possible role for TNF is the regulation of the growth of cell 
populations that make up the CL. For example, TNF was 
confirmed to be associated with endothelial cells (a cell type 
which makes up 50% of the mature CL) and, therefore, may be 
important in the regulation of endothelial cell turnover in 
the CL (angiogenesis). The period of luteolysis was selected 
to localize TNF in the CL as macrophage numbers are reported 
to increase at this time (73) and macrophages are a primary 
producer of TNF (1). It was found that TNF was not associated 
with macrophages and in fact was rare in tissue with high 
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numbers (38 cells/area) of macrophages. Moreover, TNF was 
often abundant in tissue where macrophages were absent. 
While the presence of TNF in the pig CL was verified and 
this cytokine was found to be present in steroidogenically 
active CL regardless of the reproductive state of the animal, 
the biological importance of TNF in the CL is unclear. 
Studies which would clarify the role of TNF in the pig CL 
include angiogenic or angiostatic assays to establish the 
properties of TNF for pig endothelial cells, in situ 
hybridization of luteal tissue for mRNA to establish the cell 
source of TNF in pig CL, and quantification of TNF in luteal 
tissue using more sensitive methods such as RIA or ELISA in 
order to detect any variations of TNF which may exist 
throughout the estrous cycle and pregnancy that may be related 
to biological changes in the pig CL. 
In summary, as an influx of macrophages into the pig CL 
separate from PCF treatment does not induce luteolysis, it is 
doubtful that regulation of leukocyte infiltration into the CL 
would aid in the control of functional luteolysis in the pig. 
In contrast, it is possible that TNF or other cytokines which 
can be produced by cells other than leukocytes may provide a 
means of regulating luteal function in the pig. 
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